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Abstract
Background
Concerns have been raised about the quality of the diabetes in-patient service. Nurse 
prescribing creates an opportunity to improve care for these patients.
Aim
The aim was to compare in-patients with diabetes who received standard care and an 
intervention group who had their medicines managed by a Diabetes Specialist Nurse 
prescriber.
Methods
A quasi-experiment was conducted using six wards in a single hospital trust. In-patient care 
of a convenience sample of patients was evaluated before (n=187) and after (n=265) a 
Diabetes Specialist Nurse prescriber provided a medicines management intervention. 
Prospective-data were collected to measure insulin and oral hypoglycaemic medication 
errors and length of stay. Using a smaller sub-sample of participants, sample 2 (n=56), 
additional data were collected to evaluate the intervention on self-efficacy, patients 
information needs, and to determine the types of medicines information important to 
patients. Data collection methods included documentary evidence, modified retrospective 
case-record review and questionnaires.
Findings
Errors were significantly reduced by more than 50% in the intervention group (p<0.05). The 
median length of stay was reduced by two days. The total number of errors and length of 
stay were affected by admission category (p<0.001). In sample 2, self-efficacy scores were 
increased but the extent to which patients information needs were met was inconclusive. 
Participants rated similar categories of medicines information as important.
Conclusion
A medicines management intervention provided by a Diabetes Specialist Nurse prescriber 
can have a positive effect on patient safety and quality of care in-patients with diabetes 
receive. This model of care has important implications in terms of maximising resource use 
and providing a more flexible and accessible model of service delivery. In order that the 
contribution of nurse prescribing can be fully realised further evaluation of the intervention is 
required.
Key words
Diabetes, nurse prescribing, in-patient services, quality, safety
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Chapter!: Introduction
Chapter 1: Introduction
1.1 Background
Diabetes Mellitus is one of the most common chronic diseases in both western and 
developing countries (Passa 2002). During recent years concerns have been raised 
about the prevalence of this disease in the developed world (Clark 1998). It is 
estimated that 194 million people worldwide or 5.1% of the population currently have 
diabetes, and by 2025 this will rise to 300 million (6.3%) (Deakin et at. 2005). The 
prevalence of diabetes in the United Kingdom (U.K) has also risen dramatically. 
Recent figures indicate that 2% of all men and 1.67% of all women in the U.K have a 
diagnosis of diabetes (Harvey et al. 2002, National Collaborating Centre for Chronic 
Conditions (NCCCC) 2008, Passa 2002).
Diabetes occurs as result of insulin deficiency, or resistance to the actions of insulin 
(Alberti & Zimmet 1998). Abnormalities of carbohydrate, fat, and protein metabolism 
subsequently occur as a result of the deficient action of insulin. Diabetes is 
diagnosed when a patient has a fasting blood glucose, or glucose tolerance test 
result >7.0mmol (British Medical Association (BMA) 2004, NCCCC 2008). The 
disease is classically associated with symptoms of thirst, polyuria (passing large 
amounts of urine) and if severe enough weight loss.
The majority of patients are diagnosed with either type 1 or type 2 diabetes: type 1 
diabetes has an auto-immune basis and is characterised by an absolute deficiency of 
insulin (Alberti & Zimmet 1998). It is classically a disease of rapid onset which tends 
to occur in the young (BMA 2004). In contrast, type 2 diabetes, the most common 
form of diabetes, tends to have an insidious onset and is characteristically a disease 
of the middle aged or elderly (BMA 2004). Prevalence of type 2 diabetes increases
9
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with age and more than 90% of people are diagnosed with this category of the 
condition (Nathan et at. 1997). In the U.K the prevalence of diabetes has been 
significantly affected by the changing ethnic mix of the population. People from black 
and minority ethnic communities are six times more likely to develop this disease. 
Ten percent of people aged over 65, and more than a quarter of people aged over 60 
and of Asian origin, have this disease (Audit Commission 2000, International 
Diabetes Federation (IDF) 2006).
Diabetes is a progressive condition which is associated with a number of long-term 
complications (BMA 2004, Parving 1999). The risk of macro-vascular diseases such 
as coronary heart disease (CHD), hypertension, stroke (CVA) arrd peripheral 
vascular disease (PVD) are all increased. Additionally, patients with long-term and or 
poorly controlled diabetes may also experience micro-vascular complications 
including retinopathy, nephropathy and neuropathy (BMA 2004, Deakin et al. 2005). 
The care of people with diabetes is therefore complex. A quarter of people living with 
this disease experience three or more long term conditions (Audit Commission 2000). 
In addition to the personal effects of diabetes related co-morbidities the costs to the 
National Health Service (NHS) are considerable.
Over five percent of total healthcare expenditure (approximately £25 million a day) is 
spent on the management of diabetes and its associated costs (Healthcare 
commission (HCC) 2007a). The combination of increased incidence and prevalence 
of diabetes and its associated complications means that diabetes presents an 
increasingly serious clinical and financial challenge for service provision both in the 
hospital and community setting (Bagust et al. 2002, Department of Health (DH) 
2008a). Much of the expense associated with diabetes is due to complications which 
could be reduced with good healthcare and good self-management (DH 2003a, HCC 
2007b). In addition to relieving acute symptoms (King 2003), the aim of disease
10
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management is to minimize the risk of long-term complications by achieving optimal 
control of blood glucose, blood pressure and lipids (Cox & Keogh 2004, Rachmani et 
al. 2002). Blood pressure is the pressure of the blood within the arteries, primarily 
produced by the contraction of the heart muscle. Adult blood pressure is considered 
normal at 120/80mmHg where the first number is the systolic pressure and the 
second is the diastolic pressure (BMA 2004). The term ‘lipids’ refers to the 
measurement of the two main types of fat in the blood, triglycerides and cholesterol. 
Ideally the level of cholesterol should be less than 5.0mmol/l, and fasting triglycerides 
less than 2.0mmol/l (Watkins 2003). There is considerable evidence from the 
Diabetes Control and Complications Trial (DCCT) which indicates that for every one 
percent reduction in the glycosylated haemoglobin (HbA1c) the risk of micro-vascular 
and neuropathic complications are reduced by 40-50% (DCCT 1993). Glycosylated 
haemoglobin, the primary measure used to monitor control in patients with diabetes, 
is based on the average plasma glucose concentration over a prolonged period of 
time (BMA 2004). A person with an HbA1c of less than 7% is recognised as having 
good diabetic control (NCCCC 2008).
The use of medicines is an important component of the care of patients with diabetes 
and their use in clinical practice is directed by national guidelines provided by the 
government (National Institue for Health and Clinical Excellence (NICE) 2008). Drugs 
used in the management of diabetes are designed to increase insulin resistance, 
increase insulin responsiveness or modify intestinal absorption of carbohydrate and 
exogenous insulin. Insulin injections and or oral anti-diabetic medicines correct and 
manage the symptoms in both type 1 and type 2 diabetes. Evidence from a 
systematic review however, suggests that a number of lifestyle factors including 
smoking, diet and body mass index, also play a significant part in the development of 
diabetes related complications (Deakin et al. 2005). Body mass index (BMI) is used
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in the assessment of obesity and is the body’s weight divided by the square of the 
height in metres. Adults with a BMI greater than 25 are classed as being overweight 
(BMA 2004). Additionally, there is a growing body of evidence which suggests that 
care is enhanced when patients receive a combination of drugs and non- 
pharmacological support (i.e. education and support for self-care and modification of 
lifestyle behaviours (e.g. diet, smoking and exercise)) (DH 2007, 2008b, Kroker 
2004, Rapley et al. 2003).
It is recognised that self-efficacy (SE), the belief (confidence) that one can carry out 
behaviour necessary to reach a desired goal, is a central concept of self­
management theory and a good predictor of self-care in chronic diseases such as 
diabetes (Bandura 1977, Glanz et al. 1997, Holloway & Watson 2002, Marks et al. 
2005a). It is evident that patients with diabetes who are more confident about their 
condition (i.e. have higher levels of SE), and are satisfied with the health care they 
receive (Kavanagh et al. 1993, Westaway et al. 2003), are also more likely to adhere 
to their prescribed treatment regime and self-manage their condition (Norris et al. 
2001). Additionally, they demonstrate improved health outcomes (Clark & Dodge 
1999, Marks et al. 2005a). Evidence suggests however, that less than 50% of 
patients are adherent to their medication regime, which decreases further with 
multiple chronic conditions (Anderson et al. 2005, Hugtenburg et al. 2005, Williams et 
al. 2009). Healthcare professionals must therefore make every effort to work in 
partnership with patients, ensure that they are knowledgeable about the disease and 
support patients’ ability to self-care.
Despite this, concerns have been raised about the quality of care (Audit Commission, 
HCC 2007a), and healthcare costs associated with the management of in-patients 
with diabetes (BMA 2004, DH 2008a). Patients with diabetes occupy approximately 
10-25% of beds (Audit Commission 2000, DH 2008b), and account for over nine
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percent of current hospital costs (BMA 2004). Compared to patients without diabetes 
these admissions cost six times as much, and are on average 2.6 days longer (DH 
2008b). In-patients with diabetes have reported a number of concerns about the care 
they receive including insufficient access to diabetes health professionals, doctors 
and nurses lack of knowledge about diabetes and its treatment, a lack of information 
from health professionals during admission, a lack of control over self-management 
during admission and unnecessary side-effects from medicines (Audit Commission 
2000, HCC 2007a). In-patients with diabetes also experience high numbers of insulin 
and oral hypoglycaemic (OHA) medication errors that chiefly result in prolonged 
admission (DH 2004, 2008b, National Patient Safety Agency (NPSA) 2007), and are 
a common cause of significant morbidity and complications (Heilman 2001, NPSA 
2007). There is therefore a need to improve the care and services that in-patients 
with diabetes receive.
1.2 Rationale for the study
In order to improve the quality of care that patients receive the NHS has undergone a 
radical process of reform and modernisation, a key component of which is to provide 
services that are both flexible and accessible to patients (DH 1999a, 2000, 2008c). 
Nurse-led care is seen as one means to improve healthcare provision (DH 1999a, 
2000, 2003b) and nurses have established key roles in the delivery of care in 
several areas, especially chronic diseases (Campbell 2004, McKee & Nolte 2004, 
Raftery et al. 2005). It is recognised that nurses have an important role to play in the 
services that in-patients with diabetes receive (DH 2003a, 2008b), and the
prescription of medicines by nurses should help optimize this role (DH 2006).
Policy surrounding the prescription of medicines by nurses in the U.K has undergone 
several recent changes (DH 2002, 2003c, 2005, 2006, 2009). This has effectively
13
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provided around 18,000 nurses with virtually the same prescribing rights as doctors 
(Nursing and Midwfery Council (NMC) 2010). Provided medicines are within the 
nurses’ area of competence, Nurse Independent Prescribers (NIPs) can 
independently prescribe any licensed medicine and some controlled drugs, and any 
medicine as a supplementary prescriber (but only after a diagnosis has been made 
by a doctor and a patient specific clinical management plan (CMP) been drawn up for 
the patient) (DH 2003c). Recent evidence suggests that nearly a third of these 
nurses prescribe for patients with diabetes, with the majority prescribing oral 
hypoglycaemic medication, insulin and antihypertensive drugs (Courtenay & Carey 
2008a). Findings from a national survey of U.K. Diabetes Specialist Nurses (DSN) in 
2007 also indicate that in recent years the role of the DSN has undergone significant 
development (James et al. 2009) whereby nearly 60% are now involved with 
prescribing medicines.
Although there is some evidence to suggest that nurse prescribing is being used to 
support and enhance patient services in a number of practice settings (Bradley & 
Nolan 2007, Carey et al. 2010, Courtenay & Berry 2007, Courtenay et al. 2009a), 
little is known about how nurse prescribing affects diabetes in-patient care (James 
2004). This is important given the increasing number of DSNs who are undertaking 
the prescribing role, and the need to improve the diabetes in-patient service.
This study aims to evaluate the effect of a Diabetes Specialist Nurse prescriber on in­
patient services.
1.3 Aim of the study
The aim of the study was to compare in-patients with diabetes who received standard 
care and an intervention group who had their medicines managed by a DSN 
prescriber.
14
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1.4 Research Questions
The issues and gaps highlighted from the review of the literature, as discussed in 
chapter 2, helped to formulate the research questions and hypotheses outlined 
below:
1. Do hospital in-patients, who receive a medicines management intervention 
from a diabetes specialist nurse prescriber, experience a reduction in a) the 
number of insulin and oral hypoglycaemic (OHA) medication errors and, b) 
length of stay (LOS)?
2. Do hospital in-patients, who receive a medicines management intervention 
from a DSN prescriber, report improved levels of self-efficacy (SE)?
3. Do hospital in-patients, who receive a medicines management intervention 
from a DSN prescriber, report an improvement in the extent to which their 
medicine information needs are met?
4. What types of information do patients consider important about their 
medicines?
Hypotheses
Hospital in-patients with diabetes who receive a medicines management intervention 
(MMI) from a DSN prescriber:
• will experience a reduction in the number of insulin and OHA medication 
errors (H1)
• will experience a reduced length of stay (H2)
• will report improved levels of self-efficacy (H3)
• will report an improvement in the extent to which their medicine information 
needs are met (H4)
15
Chapter!: Introduction
1.5 Rationale for research approach and methodology
An experimental approach was deemed the most appropriate research methodology 
to answer the research questions. Experimental studies in medicine and healthcare 
aim to assess the effects of specific interventions and compare those with other 
established modes of treatment and patient management. The assumption in 
experimental research is that there is some model of cause and effect, such that the 
manipulation of one variable results predictably in a change of another (Watts et al. 
2001). The assumption in this study is that by manipulating medicines management 
(from doctors and nursing staff to a medicines management intervention delivered by 
a DSN prescriber), in-patients with diabetes will experience a reduction in the number 
of insulin and OHA errors, a reduction in LOS, report improved levels of SE and 
report an improvement in the extent to which their medicine information needs are 
met. A more detailed discussion of the epistemological approach taken by the study 
and the philosophical basis of experimental design is presented in Chapter 4.
1.6 Personal Interest in the area
Initial interest in non-medical prescribing arose through my experience as a practice 
nurse and nurse practitioner in general practice. During this time the process of 
providing care to patients was frequently interrupted or delayed when I had to 
request a General Practitioner to prescribe the medicine for my patients. The costs of 
diabetes in terms of the burden of care to the National Health Service (i.e. provision 
of care), and medicines to manage the condition were also underlined by this 
experience. In addition to the progressive nature of the disease and its multiple 
associated complications, I learnt that good diabetic control was underpinned by 
encouraging and supporting patients to self-manage their condition.
16
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My interest and involvement in advanced nursing practice followed, but a lack of 
prescriptive authority continued to cause me frustration and limit my clinical practice. 
Whilst I was studying to become a nurse independent and nurse supplementary 
prescriber a few years later, I really began to appreciate how nurse prescribing could 
contribute to service delivery and make a difference to patient care. Awareness of the 
mixed response to nurse prescribing by colleagues in the medical profession and 
mixed reports in the media heightened my interest in this area. Since 2005, I have 
been involved in a number of research projects in non-medical prescribing including: 
diabetes, dermatology, paediatrics and the development of multi-professional 
prescribing. Although these experiences have provided a wealth of knowledge in this 
area, they have also highlighted the urgent need to demonstrate the contribution 
nurse prescribing can have on the services that patients receive.
This study arose from a joint working partnership between Peterborough and 
Stamford Hospital NHS Foundation Trust and the University of Reading (the 
university where I was registered as a student at the time). The Diabetes team at the 
hospital approached the University of Reading to undertake a collaborative study as 
part of their service improvement programme for in-patients with diabetes.
My study was designed as part of a broader collaborative study conducted by the 
hospital. The hospital team included Jonathan Roland (JR), Consultant Diabetiologist 
at Peterborough & Stamford Hospital NHS Foundation Trust, Mimi Hills (MH), a 
Service Improvement Manager, June James (JJ), a Senior Diabetes Specialist Nurse 
and qualified nurse prescriber, and Jenny Amps (JA), a nurse experienced in 
diabetes research.
In addition to the research questions described in Chapter 1.4, the broader study 
was designed to evaluate the medicines management intervention on a number of
17
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additional outcomes including: i) doctors and nurses levels of diabetes knowledge 
and skills; ii) patients ability to self-manage their diabetes whilst in hospital; iii) patient 
satisfaction with in-patient care; and iv) the number of readmissions experienced by 
patients. The hospital team (JR, JJ and MH) were responsible for each stage of the 
process by which these additional measures were evaluated.
1.7 Contributions to the study
The broader study was endorsed, and sponsored by JR, the clinical lead for the 
project. The hospital trust designated MH as project lead and seconded JJ to be the 
DSN prescriber who would deliver the MMI.
Supported by the hospital team (i.e. JR, JJ, and MH) and my academic supervisor, 
Professor Molly Courtenay, I was responsible for the overall study design; the 
development and piloting of tools used during data collection (e.g. the insulin and 
OHA medication error extraction chart and three questionnaires) and collection of 
questionnaire data used to answer research questions 2, 3, and 4, described in 
Chapter 1.4. During data collection I was also responsible for monitoring the progress 
of the study, keeping study records and maintaining regular contact with JJ and MH.
The documentary evidence and patient documents, described in Chapter 5.3 and 
5.44 respectively, were collected by JJ and MH, who also provided support recruiting 
patients to sample 2. JA was responsible for examining the anonymised charts of all 
patients admitted onto the six study wards during the period of data collection, as 
described in Chapter 5.4.1.1 was responsible for the analysis of data used to answer 
my research questions.
18
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1.8 Structure of the thesis
The thesis is organised into seven chapters. The first chapter introduces the study 
and reasons as to why it should be undertaken. Background information about the 
condition of Diabetes Mellitus, the complications that can arise and concerns over the 
quality of care that in-patients receive are described. The aim of the study, research 
questions and hypotheses are then presented. A rationale for the research approach 
and methodology is provided.
Chapter two reviews the literature relating to the roles and responsibilities of nurses 
who care for patients with diabetes, the effects of nurse-led care on service delivery 
and the impact that nurse-led care has on patient outcomes. Gaps in the literature 
are highlighted from which the research questions are formulated. Chapter three 
discusses the theory of medication errors, the theoretical framework used in the 
study. A rationale for the medicines management intervention and, anticipated 
benefits are then discussed.
A discussion of the epistemological approach of the study and philosophical basis of 
experimental design is presented in Chapter four. The use of a quasi-experiment, 
study design, sample selection, research setting and content of the medicines 
management intervention are then addressed in this chapter. Ethical considerations 
of the study are outlined. Chapter five discusses the methods of data collection and 
data analysis for each of the research questions. Practicalities, access, and the use 
of documentary evidence to collect demographic data are considered. Following this 
the rationale for methods of data collection (i.e. retrospective case record review and 
questionnaires) and tools used to collect the data are presented. The methods used 
in the pilot work and main study are then reported along with the research process 
and analysis of the data for each research question.
19
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Chapter six presents the results from the analysis of data collected from the 
documentary evidence, modified retrospective case record review and three 
questionnaires. Following a description of the participants the effect of the medicines 
management intervention on each outcome measure is examined. The results are 
presented under each of the four research questions. Chapter seven provides a 
discussion of the findings in relation to the literature and a critical review of the 
methodology, study strengths and limitations. The contributions the study makes to 
the body of knowledge are presented. A number of recommendations are made. A 
conclusion of the main points is then provided.
20
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Chapter 2: Review of the Literature
2.1 Overview
In order to address concerns over medication errors and shortfalls in service 
provision, guidance suggests that diabetes specialist nurses should have an integral 
role in the care that in-patients with diabetes receive (Audit Commission 2000, DH 
2003a, 2008b). In order to understand this role further, the literature evaluating the 
activity and effects of nurse-led care in diabetes is reviewed in this chapter. Literature 
is analysed from a global perspective and key methodological issues identified, 
before examining each individual study. Gaps in the literature are highlighted and 
from these, research questions, as discussed in Chapter 1.4, are identified for my 
own study which seeks to further knowledge in this area.
Specific questions that the review addresses are:
1) What are the roles and responsibilities of nurses who care for 
patients with diabetes?
2) What are the effects of nurse-led care on diabetes service delivery?
3) What is the impact of nurse-led care on the outcomes of patients with 
diabetes?
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2.2 Search Strategy
Systematic searches of CINAHL and MEDLINE were conducted for the period 
January 2000-18^ June 2010. PsyclNFO and the British Nursing Index were also 
searched but did not yield any additional results. The on-line search was 
supplemented by a hand search of the literature through references identified from 
retrieved articles. Key words (alone and in combination) included: ‘nurse-led’, ‘care’, 
‘clinics’, ‘diabetes’, ‘prescribing’, ‘activities’, ‘effectiveness’, ‘impact’ and ‘patient 
outcomes’.
2.2.1 Inclusion Criteria
• Primary research studies in the last 10 years, published in the English 
language from any country.
Studies that specifically explored the role of nurses based in primary care, or were 
conducted purely on patients in primary care settings were excluded, as the focus of 
the search was to evaluate the literature on nurses working in secondary care 
settings (including hospital in- and out-patients).
2.3 Findings
A total of 668 results were identified from the searches. However, many of these 
were duplicated citations through combining search terms. Additionally many did not 
meet the inclusion criteria. A total of twenty three relevant publications representing 
twenty one research studies met the criteria for inclusion in the review. The 
methodological quality of all included studies, specifically the design, sample size 
considerations, participant details, reliability, validity, and study findings were 
considered. As suggested by Neill (2000), this approach ensures that papers are 
reported accurately, bias avoided, validity assessed, and areas of agreement and 
disagreement across study findings identified.
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Chapter 2: Review of the Literature
Table 2.1 provides an overview of each study, including where appropriate the 
content of the intervention, main outcome measures, and strategies used to address 
reliability and validity (Polit et al. 2001). Using guidance produced by the Centre for 
Reviews and Dissemination (2006) the quality of each study was assessed against 
the following criteria:
1) Is consideration given to the size of the sample, and / or a sample size 
calculation reported?
2) Does the study include a comparison group, and / or apply a randomisation 
procedure to the sample?
3) Is a sufficient description of the intervention provided, where appropriate, and 
or / the study processes?
4) Are relevant outcome measures reported?
5) Are methods to address the reliability and validity of the study adequately 
reported i.e. content validity, pilot testing and previously validated tools?
The extent to which these five aspects of quality were met is presented as a star 
rating in Table 2.1. A five star rating indicates that the each aspect of quality was 
present in the study.
The studies reviewed used a mixture of quantitative methods, predominantly 
randomised controlled trials (RCTs) and quasi-experiments. Seventeen were based 
in secondary care (including hospital in-patients (n=6) and out-patients (n=10)) and 
four across primary and secondary care.
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Chapter 2: Review of the Literature
2.3.1 Methodological issues in the research reviewed
Research Tools
The available research evaluating nurse-led activities in diabetes is entirely 
questionnaire surveys (Carey & Courtenay 2008, Courtenay & Carey 2008a, 2008b, 
James et al. 2009, Winocour et a\. 2002). Although participants in each of the studies 
reviewed were asked to self-report the areas of diabetes care in which they were 
involved, they were not asked to indicate the frequency or amount of time they spent 
on these activities each week. Consequently, it is not possible to determine the 
extent of their involvement in these activities.
Fourteen of the eighteen studies that evaluated an intervention used standard clinical 
measures, such as blood pressure (BP) and HbA1c, to report the effect of the 
intervention on patients’ health. Studies reporting on patient outcomes (Davies et al.
2001, Kim & Oh 2003, Shibayama et al. 2007, Vrijhoef et al. 2001, Vrijhoef et al.
2002, Wong et al. 2005) predominantly used surveys to assess patient satisfaction, 
knowledge and self-care practices. Given the range of variables and previously 
validated tools that were used to assess these outcomes, it is difficult to generalise 
the findings from this aspect of work.
Study Quality
Overall study quality is poor. Using the quality assessment criteria, described in 
section 2.3 of this chapter, studies received an average three star rating. The quality 
of three studies was low (Flanagan et al. 2008, James 2004, Winocour et al. 2002). 
In contrast, four studies (Chan et al. 2006, Courtenay & Carey 2008a, Shibayama et 
al. 2007, Wong et al. 2005) were classified as being high quality and received a five 
star rating. All studies reported on relevant outcome measures. However, there was 
less consistent reporting on considerations regarding sample size and methods to 
support reliability and validity.
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Reliability & Validity
Reliability and validity issues are poorly addressed throughout and not discussed at 
all in eight studies (Cavan et al. 2001, Davidson 2003, Flanagan et al. 2008, Grey et 
al. 2002, Kim 2007, Sampson et al. 2006, Winocour et al. 2002, Young et al. 2002).
Studies exploring in-patient care have predominantly undertaken a prospective 
design (Cavan et al. 2001, Sampson et al. 2006) or been conducted as an audit 
(Flanagan et al. 2008, James 2004). However, scant methodological information is 
provided and it is unclear how the work was carried out. While it is likely that further 
details of these studies could be obtained by contacting the authors, it is important to 
note that factors such as editorial policy or space restrictions in these more medically 
based journals may have precluded detailed reporting. Consequently, less 
confidence can be placed in the evidence that the nurse intervention was causally 
related to outcomes, as relationships found may be explained by confounding 
factors.
Sampling
Sample size calculations were conducted in seven studies (Chan et al. 2006, Davies 
et al. 2001, Kim 2007, Kim & Oh 2003, New et al. 2003, Shibayama et al. 2007, 
Wong et al. 2005). However, sample size in each of the studies reviewed is variable 
(range= 40 to 28,016) and in some cases small (James 2004, Kim & Oh 2003, Young 
et al. 2002). The demonstration of statistical significance in studies with a small 
sample size should therefore be interpreted with some caution.
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Location o f data collection
Eleven of the twenty one studies were based in the U.K. Of the six studies (Cavan et 
al. 2001, Davies et al. 2001, Flanagan et al. 2008, James 2004, Sampson et al. 
2006, Wong et al. 2005) that were conducted on hospital in-patients only one (Wong 
et al. 2005) explored the effect of a nurse-led intervention on patient outcome 
measures. The generalizability and application of the findings from the review are 
therefore limited by the different types of healthcare provision and settings in which 
this work has been carried out (e.g. study country, hospital in-patient or out-patient 
clinic).
Description of the Interventions
Studies evaluating nurse-led interventions, and patient evaluation of these 
interventions, are predominantly RCTs (Barr-Taylor etal. 2003, Kim & Oh 2003, New 
et al. 2003, Shibayama et al. 2007, Wong et al. 2005). Generally, studies provided 
relatively little information about the DSNs who delivered the intervention. These 
studies also frequently lack information about the content of the intervention 
(Davidson 2003, Flanagan et al. 2008, James 2004, Sampson et al. 2006). As 
previously mentioned, while it is likely that further details of these studies could be 
obtained by contacting the authors, a lack of clarity regarding the content of 
interventions means it could be difficult to repeat the studies, and therefore reduces 
the reliability of this research.
Design o f the Interventions
Interventions were delivered to patients using a wide range of appointments and 
encounters with the DSN (Barr-Taylor et al. 2003, Cavan et al. 2001, Chan et al. 
2006, Davidson 2003, Davies et al. 2001, Denver et al. 2003, Flanagan et al. 2008, 
Grey et al. 2002, James 2004, Kim 2007, Kim & Oh 2003, New et al. 2003, Sampson 
et al. 2006, Shibayama et al. 2007, Vrijhoef et al. 2001, Vrijhoef et al. 2002, Wong et
34
Chapter 2: Review of the Literature
al. 2005, Young et al. 2002). The frequency of these encounters ranged from a total 
of five to twenty minutes, once or twice a week on the telephone, to twelve weekly 
clinic appointments. Study duration and follow-up are also variable and inconsistent 
ranging from three months up to one year. Studies reporting on in-patients with 
diabetes (Cavan et al. 2001, Davies et al. 2001, Flanagan et al. 2008, James 2004, 
Sampson et al. 2006) primarily examine measures relating to the admission period. 
The inconsistency in the content of the interventions and short follow-up periods 
make it difficult to determine the most effective approach to care.
Additionally, the majority of participants in out-patient intervention studies (Barr- 
Taylor et al. 2003, Chan et al. 2006, Davidson 2003, Denver et al. 2003, Grey et al. 
2002, Kim 2007, Kim & Oh 2003, New et al. 2003, Shibayama et al. 2007, Vrijhoef et 
al. 2001, Vrijhoef et al. 2002, Young et al. 2002) appear to have received additional 
medical input during the study period and consulted their regular physician at least 
once during the trial period. It is possible that this additional input may have had 
some influence on the findings.
Specific methodological issues relating to the individual studies are addressed within 
the main body of the review.
2.4 Themes from the literature
The following key themes were identified from the review:
• Nurses who care for patients with diabetes (n=3)
• Evaluation of nurse interventions on service delivery (n=12)
• Evaluation of nurse interventions on patient outcomes (n=6)
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Each theme is explored below.
2.4.1 Nurses who care for patients with diabetes
Several studies report findings that describe the activities of nurses who care for 
patients with diabetes. Within this theme several sub-themes emerged: ‘nurses’ 
roles’, ‘prescribing practice’, and ‘specialist knowledge’.
Nurses’ roles
Two surveys have explored the main areas of care that nurses caring for patients 
with diabetes are involved (James et al. 2009, Winocour et al. 2002). The main areas 
of care linked to their role and function include education, patient management, 
promotion of self-care, acquisition of physical skills and psychological support.
It is unclear from Winocour et al.s’ (2002) study as to whether consultant physicians 
or nurses reported on the activities of the DSN. However, subsequent sections of the 
questionnaire did require physicians to collect additional information from other 
healthcare professionals including nurses. This additional information collected from 
75% of the sample, indicated that DSNs were involved in adjusting hypoglycaemic 
agents. More than 95% reported that DSNs were involved in patient management 
and education. Where a telephone help line was in place, over 90% of respondents 
reported that DSNs were involved with this service.
Evidence from a more recent national survey (James et al. 2009) suggests that 
since 2002 the role of nurses caring for patients with diabetes has undergone 
significant development. Specifically examining the working practices of DSNs in the 
U.K in 2007, James et al. (2009) reported that, in addition to their more traditional 
roles such as education of healthcare professionals and patients, dose titration, and 
providing a telephone help-line, 90% offer independent nurse-led clinics: clinics that
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frequently provide a specialist service to renal and antenatal patients with diabetes. 
Insulin pump training was also reported to be an important area of activity by over 
50% of respondents. Importantly, nearly 60% of DSNs reported they were involved 
with prescribing medicines.
Prescribing practice
Specifically exploring the prescribing practices of nurse independent and nurse 
supplementary prescribers (NISP) in more detail, Courtenay & Carey (2008a) 
conducted a national survey in 2006, and reported that nearly a third of all qualified 
NISPs in the U.K prescribe for patients with diabetes. Whilst the majority of nurses 
were based in general practice (e.g. practice nurse and nurse practitioners), it is 
evident that nurses working in a variety of roles (e.g. midwives, children’s nurses and 
community psychiatric nurses) and settings also prescribe medicines to this group of 
patients. Further examination of the prescribing patterns of these nurses suggests 
that the majority prescribe more than six items a week and frequently prescribe oral 
hypoglycaemic medication, insulin, antihypertensive, and lipid regulating drugs 
(Carey & Courtenay 2008, Courtenay & Carey 2008b).
Specialist knowledge
Winocour et al. (2002) and Courtenay & Carey (2008a) also assessed nurses’ level 
of specialist training in diabetes. Findings from Winocour et al.s’ (2002) survey 
indicate that over 90% of DSNs had received training to educate patients and staff 
about diabetes. A basic course in general diabetes was reported by over 85% of 
respondents as a desirable criterion in the job specification for a DSN. More recently, 
Courtenay & Carey (2008a) report over 80% of NISPs who prescribe for patients with 
diabetes have a degree level qualification or higher. However, only 55% had 
undertaken a diploma, degree or masters level module in diabetes. Although another
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23% had undergone informal training in diabetes (including visits to a specialist nurse 
or Diabetiologist, in-house training, and training provided by drug companies), 20% 
had not undertaken any specialist training in diabetes. Importantly, nurses with 
specialist education in diabetes found the prescribing programme met their needs to 
a greater extent than those without, and prescribed a greater number of items per 
week for patients with diabetes compared to those without specialist training 
(Courtenay & Carey 2008b).
Summary
There are specific areas of care in which nurses caring for patients with diabetes are 
frequently involved. These areas include education, individualised care, patient 
management, promotion of self-care, acquisition of physical skills and psychological 
support. Recent evidence suggests that over the last few years the role of the 
diabetes nurse has expanded quite considerably whereby large numbers of specialist 
nurses now provide specialist nurse-led clinics. It is evident from the findings that the 
majority of nurses appear to be actively involved in titration of insulin dose and 
medicine adjustment for patients with diabetes. Furthermore large numbers of both 
specialist and non-specialist nurses appear to have incorporated the prescribing role 
into the care they provide for this group of patients. Having formal education and 
training in diabetes appears to increase the extent to which nurses use their 
prescribing qualification for patients with diabetes.
2.4.2 Evaluation of nurse interventions on service delivery
This theme examines twelve studies that have evaluated the effect of a nurse-led 
intervention on service delivery of patients with diabetes. A number of sub-themes
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emerged from the literature including ‘patient and staff education’, ‘education and 
management of patients’, and ‘disease management protocols’.
Patient and staff education
There is some evidence to suggest that an increased amount of education for 
diabetic patients has a positive effect on a number of areas of diabetes management 
(Flanagan et al. 2008, Grey et al. 2002). These areas include glycemic control, 
emergency admissions, clinic attendance rates and length of hospital stay.
Grey et al. (2002) conducted a prospective repeated measures study to examine the 
effects of a patient education intervention on patients with diabetes in a minority 
population. In addition to regular quarterly attendance at the Diabetes Life Care 
programme and appointments with their physician, any further patient contacts with 
the nurse over the remaining period were then determined by individual need. 
Outcome measures included glycemic control, adherence to standards of service 
provision, hospital admissions and visits to the emergency department. At three 
months, significant improvements in HbA1c were identified in 142 out of 227 patients. 
At six months, these improvements remained for 66 patients. Adherence to the 
standards of care for annual eye and foot examination were also significantly 
improved.
More recently, Flanagan et al. (2008) explored the effect of an educational 
intervention provided by a team of five specialist diabetes nurses on length of stay 
and the number of emergency admissions. Focussing on early identification and 
treatment of patients with diabetes, an education programme for each hospital ward 
was established. A rolling programme of diabetes related education sessions for 
healthcare professionals was also provided. Although the intervention is poorly
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described by the researchers it is evident that a specialist nurse visited each ward 
daily. Overall length of stay was reduced but not to a significant level. However, there 
was a significant reduction in length of stay for diabetes emergency admissions.
The effect of education provided by a DSN (and qualified supplementary nurse 
prescriber) on glycemic control was also explored by James (2004). Additional 
measures included the number of hypoglycaemic events, patient satisfaction and 
staff knowledge. Hypoglycaemia, occurs when blood glucose drops below 3.0mmol/l. 
This causes a number of symptoms such as dizziness, sweating, shaking and 
palpitations that usually go away 10 to 15 minutes after eating sugar. If left untreated 
it can lead to seizures, coma, and even death (IDF 2006). Data collected included 
information on the medication used to treat diabetic patients, changes to medication 
and adverse events. Patients and staff also completed a short questionnaire. These 
questionnaires measured patient and staff satisfaction with the role of the DSN 
prescriber and staff knowledge with regards to the management of diabetes.
James reports a reduction in the number of hypoglycaemic events and improved 
glycemic control. However, it is unclear how much contact or education patients and 
staff received from the DSN prescriber. Only nine out of the forty two patients and 
nineteen out of the twenty eight staff completed questionnaires. Staff were found to 
be highly supportive of the project and reported that their knowledge of how to 
manage diabetes had improved. Similarly, patients reported high levels of 
satisfaction with the role of the DSN prescriber.
Education and management of patients
Six studies (Barr-Taylor et ai. 2003, Cavan et al. 2001, Chan et al. 2006, Kim 2007, 
Sampson et al. 2006, Young et al. 2002) have examined the effect of an intervention
40
Chapter 2: Review of the Literature
(combining education, the adjustment (or changes) to patient medications and or the 
use of the telephone or web) provided by a DSN, on length of stay, number of 
occupied bed days, HbA1c, lipids, BMI, symptoms of hypoglycaemia, patient and 
physician satisfaction, and quality of care.
Over a two year period, Cavan et al. (2001) examined the effect of an educational 
intervention provided by a DSN advisor, and subsequent adjustment of insulin and 
hypoglycaemic medications using medicine protocols on hospitalised diabetic 
patients. Advice on discharge planning was also provided. During their hospital stay 
patients received an average of two visits from the DSN. Outcome measures 
included length of stay, number of occupied bed days and the number of doctors and 
nurses who used the DSN advisor to support their decisions.
Compared to computer records from the previous year, median length of hospital 
stay was significantly improved for both medical and surgical patients. Although not 
at a significant level, bed occupancy rates for patients with diabetes were reduced 
representing a net saving of 4,171 bed days. The average length of stay for surgical 
patients showed marginal improvement. However, the average length of stay for 
medical patients increased. All twenty eight doctors surveyed reported that they had 
used the DSN advisor and found it a useful service. Additionally, nursing staff 
reported that the DSN had enabled them to access appropriate and rapid advice on 
patient management.
The effect of a intervention involving education and insulin dose adjustment provided 
by a DSN was also examined by Young et al. (2002). Using poorly controlled and 
insulin treated diabetic patients these researchers conducted a prospective audit. 
Interventions took place on initial referral to the DSN and two weeks later. Any 
additional patient contacts with the DSN over the remaining six month period were
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then determined by individual need. Outcome measures included HbA1c, BMI, and 
insulin dose. Twenty seven of the forty three patients seen by the DSN improved with 
regards to lowered HbA1c and increased insulin dose. BMI did not show any rise. 
The remaining sixteen patients showed no corresponding improvement with regards 
to HbA1c and there were no significant changes in insulin dose or BMI.
Sampson et al. (2006) examined the effect of an educational and clinical intervention 
provided by a DSN on in-patients with diabetes. Combining adjustment of insulin and 
oral hypoglycaemic medications and discharge planning with patient and staff 
education these researchers analysed bed occupancy data for medical and surgical 
in-patients for six years, with the intervention in place for the final two years.
Comparing bed occupancy data of in-patients with diabetes to matched groups of 
patients who did not have diabetes, before and after the intervention, mean excess 
bed days was the only outcome measure reported. Although information on the 
number of visits the DSN made to each patient and the amount of education provided 
to staff members is not provided, following the intervention mean excess bed days 
were significantly reduced with a resultant net saving of 700 bed days for those aged 
under sixty, and 1330 bed days per year for those aged 61-75 years.
Barr-Taylor et al. (2003) used a RCT to determine the effect of a DSN intervention on 
HbA1c, BP, lipids, quality of life, physician visits, hospital admissions, emergency 
room visits, patient satisfaction and physician satisfaction. In this study, patients with 
poorly controlled diabetes and one or more major co-morbid conditions were 
randomised to either the intervention or control group. Patients in the control group 
received written information encouraging them to maintain contact with their 
physician and to attend general diabetes education classes. In addition to regular
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scheduled telephone calls any further contact for patients in the intervention group, 
was then determined by need.
Patients in the intervention group attended on average three and a half group 
sessions, received on average thirteen phone contacts, and five changes to their 
medication regime from the DSN. Self-report forms were completed by patients 
before and after the study. Sixty one intervention patients and fifteen physicians (with 
two or more intervention patients in the study) were invited to complete a survey to 
assess their satisfaction with the programme (fifty seven patient and thirteen 
physician completed questionnaires were returned).
The effect of the intervention on BP was inconclusive and there were no significant 
changes to the number of physician visits, admissions to hospital, or emergency 
room visits. Overall, a significantly higher number of patients randomised to the 
intervention group achieved their HbA1c goal. Additionally, mean reductions in 
HbA1c, and cholesterol were significantly greater in these patients. Patients in the 
control and intervention group reported improved mood and a high level of 
confidence to engage in self-care behaviour. The majority of patients reported high 
levels of satisfaction with the programme reporting that the programme was very 
helpful in preparing them to self-manage their condition. Similarly, staff were found to 
be highly supportive of the DSN intervention with 70% strongly recommending that 
the programme be adopted by their healthcare system.
These findings are further supported by Chan et al. (2006) and Kim (2007). Chan et 
al. adopted a quasi-experimental design to determine the effect of a diabetes nurse 
clinic intervention on patients with poorly controlled type 2 diabetes on glycemic 
control. Other outcome measures were BP, weight, healthcare utilization and quality 
of care. Patients attending a regional out-patient clinic were randomised to either a
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control or intervention group. The emphasis of the intervention was to promote self­
management behaviours, communicate the importance of lifestyle changes, and 
provide regular attention and feedback on patient’s monitoring.
At twelve weeks, the HbA1c, and systolic BP of patients in the intervention group had 
improved significantly when compared to baseline measures. Healthcare utilization 
had also significantly decreased (i.e. admission or emergency room attendance). A 
questionnaire completed by participants before and after the intervention identified a 
significant improvement in the overall quality of care of patients in both groups. A 
possible explanation for this provided by the researchers was that patients in both 
intervention and control groups felt more engaged and ultimately more satisfied in the 
care that was provided.
Using a RCT, Kim (2007) explored the effects of a twelve week web-based nurse 
intervention on glycemic control. In this study, hospital out-patients with type 2 
diabetes who were able to self-test blood glucose, inject insulin if necessary, had 
access to the internet at home and owned a cellular phone, were randomized to 
either the intervention or control group. Patients in the control group maintained usual 
contact with their diabetes specialist doctor and were provided with the usual 
recommendations about medication, education and lifestyle modification.
Patients in the intervention group participated in web-based education, medication 
adjustment and frequent self-monitoring of blood glucose. Additionally they were 
asked to electronically record their blood glucose levels and medication dosage 
information on the web at least once a week. Based on this information the nurse 
then used the internet and short message service of the cellular phone to 
recommend any necessary dose adjustments. Glycemic control was significantly 
improved in patients whose HbA1c was > 7.0% at baseline. Additionally, in patients
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whose baseline HbA1c was <7.0%, fasting glucose, and two hour plasma-glucose 
were also reduced; however this was not at a level of statistical significance.
Two further studies (Denver et al. 2003, New et al. 2003) provide additional evidence 
with regards to the positive effects of a specialist nurse intervention combining 
education and adjustment of patient medications. New et al. (2003) used a RCT to 
examine the effect of specialist nurses on raised BP, raised total cholesterol and 
mortality. Eligible diabetic patients who presented at their annual review with raised 
BP (> 140/80 mmHg), raised total cholesterol (> 5.0 mmol), or both were randomized 
to the nurse-led hypertension clinic, the nurse-led hyperlipidemia clinic, or usual care. 
Participants attended a mean number of two visits for both intervention groups.
A higher number of patients randomized to the specialist nurse-led clinic achieved 
their treatment targets. However, the effect of the intervention on hypertensive 
patients was not significant. The authors suggest that this can be explained to a large 
extent by the concurrent implementation of local hypertension guidelines, whereby an 
ongoing reduction in BP in the whole study population was identified. In contrast the 
hyperlipidemia-only intervention group demonstrated significantly improved 
attainment of targets. Additionally, the two intervention groups demonstrated a 
significant reduction in patient mortality.
These findings are further supported by Denver et al. (2003). These researchers 
used a RCT to determine the effect of a nurse-led hypertension clinic on systolic BP, 
diastolic BP, lipids, HbA1c, and ten year CHD and stroke risk scores. Patients 
attending a hospital clinic with type 2 diabetes, treated hypertension, and a seated 
BP > 140/80 mmHg were randomly assigned to the intervention or control group. 
Patients in the intervention group were three times more likely to reach a target 
systolic BP< 140 mmHg and experienced a significant reduction in ten year CHD and
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stroke risk scores. However, there were no significant differences between the two 
groups in the reduction of diastolic BP, lipids, or HbA1c.
Disease management protocols
One study (Davidson 2003) examined the effects of a DSN-led service on enhanced 
patient compliance and patient management. Using a number of DSN-led protocols 
to manage and titrate medicines, this researcher examined the effect of nurse-led 
care, on the ten standards of service provision, (as outlined by the American 
Diabetes Association (ADA)), for a randomised sample of diabetic patients in a 
minority population. Standards of care were significantly improved in seven out of 
the ten areas described by the ADA for patients who had received the intervention. 
These areas included diabetes education, nutrition counselling, HbA1c, lipid and 
renal profile, foot and eye examination. Additionally, patient HbA1c levels improved.
Summary
Improved glycemic control, cost effectiveness and decreased length of hospital stay 
are the main benefits of nurse-led interventions in diabetes care. Other positive 
benefits include improved patient satisfaction, improved glucose monitoring, 
improved quality of care and increased clinic attendance. Additionally the rate 
patients were re-admitted to hospital was also reduced. The findings of research 
examining nurse-led care on BP and cholesterol are inconsistent. It is evident that 
healthcare staff are supportive of the DSN. However, the effect of the role of the DSN 
on staff knowledge and patient management is currently unreported.
Disease management protocols are the main mechanism by which nurses adjust and 
titrate medicines for patients with diabetes. The scope of professional practice and 
nurses’ involvement in the adjustment and titration of medicines are varied. This 
appears to be related to the nurses’ area of clinical practice and competence in the
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management of diabetes. There is negligible evidence exploring the effect of nurse 
prescribing.
2.4.3 Evaluations of nurse interventions on patient outcomes
The final theme reports on six studies that have been conducted to evaluate a nurse 
intervention on patient outcomes. Several sub-themes emerged in this area of the 
review: ‘patient self-care’, ‘quality of life’, ‘quality of life and self-care’.
Patient self-care
Two studies (Kim & Oh 2003, Wong et al. 2005), both RCTs, have been conducted to 
examine the effect of a nurse intervention on patient self-care, glycemic control, and 
patient satisfaction.
In order to examine the effect of a nurse intervention on diabetes adherence and 
glycemic control, Kim & Oh (2003) randomised patients with type 2 diabetes from a 
city hospital clinic to either the intervention group or routine care. Each participant 
received on average sixteen calls from the nurse, each lasting on average twenty five 
minutes. Patients who had received the intervention demonstrated significantly 
increased levels of self-care with regards to glucose monitoring and diet adherence. 
Additionally, patients’ HbA1c levels were significantly improved.
Similar findings are reported by Wong et al. (2005). This researcher randomly 
assigned patients in a regional hospital, who were deemed fit for discharge by a 
doctor (except for their glycemic control) to receive the intervention or routine care. 
Patients in the control group remained in hospital and continued to receive routine 
care. Data was collected at baseline, twelve and twenty four weeks. This data 
included HbA1c, length of stay, emergency department attendance, adherence and
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patient satisfaction. At twenty four weeks the HbA1c of patients in the intervention 
group had significantly improved. Additionally these patients had significantly higher 
blood monitoring and exercise adherence scores (at twelve and twenty four weeks) 
and a shorter hospital stay with estimated savings of HK$11,888 (£960) per patient. 
Both groups of participants reported similar high levels of patient satisfaction with 
nurse-led diabetes care and education.
Quality of life
Four studies (Davies et al. 2001, Shibayama et al. 2007, Vrijhoef et al. 2001, Vrijhoef 
et al. 2002) looked at the effect of a DSN intervention on quality of life (QOL). Davies 
et al. (2001) used a RCT to examine the effect of a DSN led intervention on in­
patients referred to the DSN service. Other effects examined by these researchers 
included length of hospital stay, time (in days) to readmission, use of community 
resources, patient satisfaction, diabetes knowledge and disease specific quality of 
life. Patients were randomised to receive either the intervention or routine care. 
Those randomised to the intervention group, received individual structured patient 
education from the DSN who also provided practical management advice to ward- 
based doctors and nurses. Although the amount of contact time between patients in 
the intervention group and the DSN is unclear, it is clear that the intervention was 
delivered by a team of four DSNs.
Diabetes knowledge and quality of life were assessed using questionnaire surveys at 
the point at which participants were randomised, and one week following hospital 
discharge. Additionally a patient satisfaction questionnaire was distributed one week 
post-discharge. Overall quality of life remained unchanged. Patients in the 
intervention group were significantly more satisfied with the care they had received, 
significantly less likely to use community resources and were more knowledgeable
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about their diabetes. When compared to the control group, the median length of stay 
was significantly lower in patients in the intervention group, producing an average 
saving of £436 per patient.
Shibayama et al. (2007) similarly adopted a RCT to determine the effect a of one-to- 
one lifestyle counselling intervention provided by a DSN on quality of life, glycemic 
control and modification of cognition and behaviour. Patients in the control group 
received routine care. Those in the intervention group received routine care plus 
monthly appointments (of eight to seventy six minutes duration) with the DSN over a 
one year period, where they received individualised structured information, education 
and lifestyle advice. Additionally they were encouraged to problem solve, set goals, 
and identify barriers to behaviour.
Health related quality of life, and cognitive and behavioural modification were 
assessed using a combined questionnaire at baseline and one year follow-up. 
Patients in the intervention group showed significantly higher scores in both cognition 
and behaviour modification. However, glycemic control and quality of life remained 
unchanged.
Quality o f life and patient self-care
The effect of a DSN intervention on quality of life and patient self-care has also been 
examined in the Netherlands by Vrijhoef et al. (2001, 2002). A quasi experimental 
design was used by these researchers to examine the effect of a shared care model 
(with the DSN as the main care provider) for patients with stable type 2 diabetes. 
During the year long studies, data on clinical status and glycemic control were 
collected at baseline, six and twelve months.
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The group based protocols directed the DSN through several areas of patient care 
including consultations, interpretation of laboratory results, management, advice and 
education. Quality of life remained unchanged. In both studies, improved levels of 
knowledge were found in patients who received the intervention. This was also a 
significant finding in those patients who had participated in the pilot study. Self­
regulation in both studies had also significantly improved. The level of patient self- 
care in these studies remained unchanged.
The most significant effect of the research conducted by Vrijhoef et al. (2001 & 
2002), was the significantly improved level of glycemic control. In both studies a 
significant improvement in total cholesterol was also identified. Further positive and 
significant findings in the pilot study include improved mean diastolic BP, and 
triglycerides. Satisfaction rates were high and fairly stable across both studies.
Summary
Patient evaluations of nurse-led care report improved self-care and patient 
knowledge. Additionally, marginal improvements to quality of life and, patient 
satisfaction have been reported. The impact on several different measures has been 
explored including diabetic symptoms, HbA1 c, length of hospital stay, and costs. The 
effects on these outcomes are variable and inconclusive. In each intervention, a 
strong emphasis was placed on education and support provided by a DSN. Disease 
management protocols were the main mechanism by which nurses were able to 
adjust and titrate medicines for patients with diabetes.
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2.5 Gaps in the literature
This review has examined the literature by exploring the role and responsibilities of 
nurses who care for patients with diabetes and the contribution that nurses make to 
the care of this group of patients. There are gaps within the literature with respect to 
knowledge and understanding, methodology and theory, each of which is explored 
below:
a) Gaps in knowledge and understanding
The review of the literature has established that patients with diabetes experience a 
number of benefits when they receive nurse-led care including improved glycemic 
control, reduced length of stay, improved glucose monitoring, improved knowledge 
and higher levels of patient satisfaction. The care nurses provide to patients with 
diabetes includes a strong emphasis on patient education, support, advice and 
medicines management.
The literature reveals that although national policy highlights the importance of 
reducing medication errors and improving the quality of care that in-patients with 
diabetes receive, the effect of diabetes nurse-led care on medication errors is 
unreported. The majority of studies use standard clinical measures to report the 
effect of the intervention on patients’ health e.g. BP and HbA1c. Few studies have 
reported on patient outcome measures related to quality of care e.g. patient 
satisfaction, ability to self-care, and only one Hong Kong based study reported on 
patient outcome measures for in-patients with diabetes.
Medicines protocols appear to be the main mechanism by which nurses have 
traditionally been responsible for the management of diabetes care. However, the 
literature in relation to nurses’ roles indicates that nurses are increasingly
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incorporating the prescribing role into the care they provide to patients with diabetes. 
While nurse prescribing has been introduced as a means to improve access to 
healthcare professionals and service provision little attempt has been made to 
evaluate this role on diabetes services. Therefore, there is a need for evaluative 
research to explore the benefits of nurse prescribing and to provide objective data on 
in-patient outcome measures such as medication errors and length' of stay. 
Intervention studies need to provide a rationale for their content and incorporate the 
prescribing role into their design. Additionally there is a need to explore the effects of 
nurse-led care on other quality of care measures that in-patients with diabetes 
experience such as their ability to self-care, and the extent to which their information 
needs are met.
b) Gaps in methodology
There is a lack of outcome studies on in-patients with diabetes which require an 
experimental approach and a lack of data looking at long-term study effects. Clearly, 
there is a need therefore for future studies on in-patients with diabetes to adopt both 
an experimental approach and a longitudinal design.
c) Gaps in theory
The literature reveals that research in this area tends to adopt an experimental 
approach and is highly medically orientated. Consequently it is not underpinned by 
theory or located within a critical framework. Intervention studies primarily report 
clinical measures such as cholesterol, BP and HbA1c. Attempts are made to report 
on patient satisfaction, but this is not explored in any detail.
The issues and gaps highlighted within the review of the literature form the basis of 
the research questions formulated within the quasi-experiment as described in
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Chapter 1.4. The next chapter of the thesis explains the theory of medication errors, 
the theoretical framework used in this evaluative study of a diabetes specialist nurse 
prescriber on in-patients with diabetes.
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3.1 Overview
The roles and activities of nurses who care for patients with diabetes and the 
contribution that nurses can make to this group of patients were demonstrated in the 
previous chapters. While the number of DSNs involved with prescribing medicines is 
increasing (James et al. 2009), little attempt had been made to explore how the 
prescribing role can be used to improve diabetes in-patient services, or reduce the 
number of medication errors that this group of patients experience. Given that 
national guidance highlights that DSNs should have an integral role in improving 
diabetes in-patient services (DH 2008b), evaluation of the prescribing role is 
required.
This chapter will discuss the theoretical framework used. The rationale for the 
medicines management intervention used in the study and, anticipated benefits to 
patient care will be explained.
3.2 Theory of Medication Errors
Based on the theory of medication errors (Leape 1994, Reason 1990), a general 
systems theory (von Bertalanffy 1968), this study aimed to develop an intervention 
led by a DSN prescriber that would address a number of factors associated with 
medication errors (ME) and shortfalls in service provision that in-patients with 
diabetes experience (DH 2003a, 2008b, HCC 2007b).
There is substantial evidence to suggest that most MEs involve a chain of problems, 
and a variety of systemic features such as the level of the task, team, work 
environment and the wider organisational context (Dean et al. 2002, Heilman 2001,
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2004, Leape 1999, Reason 1990, Vincent 2003). Reason (1990), Vincent et al. 
(1998) and Dean et al. (2002) describe two types of error; slips and lapses, and 
mistakes. Slips and lapses are errors of action and occur when there is a break in 
routine and attention is diverted. In comparison, mistakes which are more difficult to 
detect are rule and knowledge based errors, and are errors of conscious thought. 
Mistakes commonly result from a lack of knowledge or misperception of the situation 
with the subsequent application of the wrong rule to the situation.
It is recognised that ME occur when human system factors interact with the process 
of delivering medicines to produce an unintended or potentially harmful outcome 
(Vincent 2003). The system of providing medications to patients is complex with 
multiple sub-processes and as a result errors can occur at each stage of the process 
by which patients receive their medication e.g. prescribing (including transcribing or 
physician ordering), dispensing, preparation, administering and monitoring (Clancy 
2004, NPSA 2007). The rate at which errors occur at each stage of the medication 
process also varies. For example, a recent review of 59,802 ME reported to the 
National Reporting and Learning System (NRLS) in the U.K between January 2005- 
2006 (NPSA 2007) identified that 59% of errors occurred during the administration of 
medicines, 18% preparation or dispensing, 16% prescribing and 9% monitoring.
Many specific factors have been repeatedly associated with errors i.e. slips, lapses 
and mistakes that occur in the system of delivering medicines to patients including a 
lack of knowledge of the drug and the patient, poor history taking, a high work load, 
failure to follow policy and procedure, miscalculations of drug dose, errors in decimal 
points, medications with similar names, use of abbreviations and complicated dosage 
regimes (DH 2004, Leape et al. 1995, Lesar et al. 1997, NPSA 2007, O'Shea 1999, 
Wilson et al. 1995).
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Although errors are an intrinsic part of mental functioning and cannot be totally 
eliminated (Anderson & Webster 2001, loannidis & Lau 2001, Reason 1990), there is 
considerable evidence to suggest the fundamental cause usually lies in a variety of 
systemic features operating at the level of the task, the work environment and the 
wider organisational context. The primary objective of a system designed to deliver 
medicines safely is to make it difficult for individuals to err (Leape 1994). Ideally, a 
system as Leape (1994) suggests, will automatically correct errors or have 
mechanisms in place to at least detect errors in time for corrective action. A 
structured and systematic approach to reducing medication errors means that 
instead of focusing on the individual the focus is on the conditions under which 
individuals work and how these conditions predispose individuals to err (DH 2004).
3.3 The Medicines Management intervention
Insufficient access to diabetes health professionals, doctors and nurse lack of 
knowledge about diabetes and its treatment, a lack of information from health 
professionals during admission, a lack of control over self-management during 
admission and unnecessary side-effects from medicines are nationally recognised 
shortfalls in diabetes in-patient services (Audit Commission 2000, HCC 2007a). 
Similar shortfalls in service provision were identified in the study hospital following an 
audit conducted as part of an ongoing programme to improve the care in-patients 
with diabetes receive (James 2003). It was evident that the shortfalls identified in the 
study hospital by James (2003) were rooted across several parts of the process by 
which they received their insulin and OHA medication i.e. prescribing, administration 
and monitoring.
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The medicines management intervention (MMI) was therefore developed to improve 
the care in-patients with diabetes receive. It was anticipated that combining key 
components from the established role of the DSN (e.g. medicines management, 
education, support and promotion of self-care) (Carey & Courtenay 2007) with the 
relatively new role as a prescriber would help improve the prescribing, administration 
and monitoring stages of the process by which in-patients with diabetes received 
their insulin and OHA medication.
There were 3 stages to the MMI:
1) Medication review by a DSN prescriber
2) Education and support for patients and healthcare professionals i.e. doctors 
and nurses
3) Encouraging patients (and their families) to self-care and manage their 
condition
A rationale for each stage of the MMI is presented below:
1. Medication Review by a DSN prescriber
There is considerable evidence to suggest that regular medication review is one 
effective way to optimize drug therapy, check compliance and concordance, improve 
patient understanding, improve health outcomes, and reduce the likelihood of 
medicine related problems i.e. adverse events, medication errors and unnecessary 
side-effects (Cohen et al. 2005, HCC 2007a, Medicines Partnership 2002). 
Importantly, it is recognised that the effect of medication review is maximised when it 
is undertaken in a systematic way and conducted by a competent person (Medicines 
Partnership 2002).
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In addition to providing a systematic approach to care, it was believed that if the DSN 
prescriber conducted a medication review diabetes in-patients would have access to 
a knowledgeable and experienced diabetes health professional during their 
admission. It was anticipated that the DSN prescribers’ high level of technical 
competence and knowledge of diabetes medicines management would help optimize 
drug therapy, improve patient understanding and reduce the number of medicine 
related problems. It was expected that this in turn would help reduce the number of 
medication errors and length of stay that in-patients with diabetes experience.
2. Education and support for patients and staff 
Evidence suggests that the education and knowledge of healthcare professionals are 
key factors that contribute to the errors experienced by in-patients with diabetes (DH 
2004, Kowiatek et al. 2001, NPSA 2007). Additionally, the literature suggests that 
patients with diabetes who are knowledgeable about their condition are more likely to 
adhere to their prescribed treatment regime, self-manage their condition (National 
Prescribing Centre 2005, Norris et al. 2001) and demonstrate improved health 
outcomes (Clark & Dodge 1999, Marks etal. 2005b).
Therefore, it was envisaged, that if the DSN prescriber provided structured individual 
ward-based patient education sessions appropriate to need (including information on 
the patient’s condition, management of medicines, medication changes and self­
management) patients would report improved self-efficacy: additionally the extent to 
which their information needs met would also be enhanced.
Furthermore, it was expected that if medical and nursing staff received individual high 
quality education sessions appropriate to need, (including information on the 
treatment regime of each patient, drug actions and dose, drug interactions and
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adverse effects), this learning would be applied to the practice setting, and patient 
care would improve with the number of medication errors potentially being reduced.
3. Encouraging patients (and their families) to self-care and manage their 
condition
It is evident from the literature that patients with diabetes who are more confident 
about their condition are also more likely to adhere to their prescribed treatment 
regime and self-manage their condition (Norris et al. 2001). This stage of the 
intervention was based on the chronic disease self-management programme 
(CDMP), developed by Lorig et al. (1996), a well established framework which 
encourages patients to self-care and manage their condition. The CDMP 
incorporates cognitive and behavioural modification strategies suggested by Bandura 
(1977). These strategies are designed to enhance self-efficacy and include weekly 
action planning, group problem solving, and individual decision making. Additionally, 
information from a well qualified and highly credible person appears to have a greater 
impact on efficacy expectations than messages from a less credible source (Marks et 
al. 2005b).
Several experimental studies (Dongbo et al. 2003, Hammond et al. 1999, Lorig et al. 
1999, Wright et al. 2003) have explored the effect of the CDMP on patients with a 
variety of chronic diseases including arthritis, diabetes, and asthma. The findings 
indicate that improved health behaviour, psychological well-being, quality of life, self- 
efficacy, and reduced hospital admissions are all benefits from interventions that 
adopt this programme. Additionally, it is evident that interventions which adopt a 
format similar to the CDMP are more successful than those that use traditional 
methods of managing patients (Marks et al. 2005b).
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It was envisaged therefore that the support and encouragement provided by the DSN 
prescriber would have a positive effect on patients’ ability to self-care and improve 
self-efficacy and the extent to which their information needs were met.
An experimental approach was identified as being the most appropriate research 
methodology to support this theoretical framework and answer the research 
questions. The. use of the experimental approach is discussed in the following 
chapter.
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4.1 Overview
This chapter explores the epistemological approach of the study and the 
philosophical basis of experimental design, specifically focusing on quasi­
experiments. The study design, sample selection, research setting, and content of 
the medicines. management intervention are then considered. Finally, ethical 
considerations of the study are discussed.
4.2 Epistemology
Contemporary healthcare and medicine in particular prides itself on its objective 
status which has been achieved through longstanding scientific accomplishment. 
Objectivism is the epistemological view that things exist as meaningful entities 
independently of experience. Thus, the aim of research is to attempt to find objective 
truth and meaning. This is the epistemology underpinning the positivist stance.
During the three distinct generations of positivist philosophers e.g. Locke, Hume and 
Comte in the early 18th and 19th centuries, Ayer (1936) and Carnap (1932) in the 
early 20th century, and Hemple (1965) in the post war period, the ideas associated 
with positivism have been developed, challenged and restated a number of times. 
The key elements of this approach remain however, largely unchanged (Crossan 
2003, Outhwaite 1987). Therefore, there are a number of implications for research 
based on this approach as explained by Hughes & Sharrock (1997), Easterby-Smith 
etal. (2001), and Crossan (2003).
Positivism adopts a clear quantitative approach to investigation as the belief is, this is 
the only research from which valid generalisations can be made. Positivism assumes
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that things can be studied as hard facts and the relationship between these facts can 
be established as scientific laws (Crossan 2003, May 1993). Any data collected 
within positivism is therefore theory driven and designed to test the accuracy of the 
theory under investigation (Black 2003). Consequently, rather than using human 
beliefs or interests, objective criteria tend to be used to determine the topic of interest 
and how to study it: the aim of which is to identify causal explanations. In addition to 
the topic of interest being operationalised in a way that enables facts (data) to be 
measured objectively, the role of the researcher is also believed to be independent of 
the subject under examination. Furthermore, it is believed that if problems are 
reduced to the simplest elements they will be better understood.
A major criticism of the positivist approach is that it does not provide the means to 
examine human beings and their behaviours in an in-depth way (Crossan 2003, 
Playle 1995, Whall & Hicks 2002). As Playle (1995) and Crossan (2003) assert, 
humans are not objects and are subject to many influences on behaviour, feelings, 
perceptions and attitudes that positivists would reject as irrelevant. Consequently, 
there is a denial of the importance of influence and context of the relationship 
between the researcher and research participant. Data are seen as being gathered 
rather than created and the researchers own influence is not acknowledged (Playle 
1995). Critics of the positivist approach also argue that it yields useful but limited data 
on the phenomenon under investigation (Crossan 2003, Playle 1995).
Post-positivism however, provides an alternative to the traditions and foundations of 
positivism, and aims to describe and explore in-depth phenomena from a qualitative 
perspective (Crossan 2003, Parahoo 2006, Playle 1995). In contrast to positivism, 
the post-positivist approach recognises the intricate relationship between individual 
behaviour, attitudes and external structures. It additionally assumes that reality is 
multiple, subjective and mentally constructed by the individual. The approach fits well
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with nursing which has historically dealt with understanding patients’ values and 
meanings (Playle 1995, Whall & Hicks 2002). The subjective experience of the 
patient and ensuring an individualised, holistic approach to care are also key 
components of modern healthcare services (DH 2008c, Whall & Hicks 2002).
A key criticism of the post-positivist approach however, is the subjective nature of the 
inquiry and lack of control over researcher bias (Crossan 2003, Parahoo 2006). 
Other limitations of this approach generally relate to the interactive and participatory 
nature of the qualitative methods used during data collection. Furthermore, it is 
argued that qualitative research lacks both reproducibility and generalizability 
(Crossan 2003, Polit et al. 2001).
Given the multifaceted, complex and dynamic nature of nursing practice it is evident 
that neither positivism nor post-positivism should be the sole approach to scientific 
inquiry. While there is a danger in the acceptance of objectivity that not only will there 
be a continuing dehumanization of the research process but also the subjects of the 
research themselves (Playle 1995), it is evident ascribing to only one view will lead to 
an incomplete nursing science (Crossan 2003, Giddings & Grant 2007, Whall & Hicks
2002). Positivistic views in medical science are strong and enduring and at a time of 
increasing skill mix and interdisciplinary practice these views may greatly affect the 
continued development of nurses’ roles. With this in mind, positivism was deemed to 
be the most the appropriate philosophical approach to test the hypotheses and 
answer the research questions as discussed in Chapter 1.4.
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4.3 The Experimental Approach
Experiments allow comparisons between different approaches to treatment and 
interventions across all areas of healthcare. Rooted in traditional scientific method, 
and aiming to remain impartial and objective, the emphasis is on the investigation of 
what may be directly observed (Watts et al. 2001). Using a set of orderly disciplined 
procedures, the researcher systematically moves from defining the research question 
to data collection and analysing the findings.
In the late 19th century, John Stuart Mill and his followers were instrumental in the 
development of experimental methods (Wilson-Barnett 1991). Unhappy with simply 
counting the observations (variables) of interest, they wanted to change things and 
put nature to the test and evaluate the results. The chief premise of the approach is 
that groups of similar subjects are selected and treated the same apart from at least 
one factor which is introduced or manipulated to influence the outcome. By 
comparison and evaluation of the different groups, factors can be identified which 
help to infer a causal link. Advantages of this approach include the ability to test 
hypotheses, and the capacity to compare effects of interventions to generate a level 
of confidence for estimated values uncovering influences and patterns of interactions 
(Wilson-Barnett 1991). Experimentalists seek to achieve consistency in observations, 
reliability in measures across subjects, and reproducible findings. However, if the 
observations are not systematic and replicable, the theory can lack scientific rigour 
and robustness. The experiment by nature of the study design can be replicated by 
other investigators and by consistency of findings achieve some degree of 
confidence in generalisations (Poole & Jones 1996).
Substantial knowledge in healthcare has been built through experiments, and 
significant advances in understanding have been provided through experimental
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evidence, including the role of psychological and physical rehabilitative interventions 
in aiding adaptation and recovery after major illness (Wilson-Barnett 1991). 
Increasingly, the results from randomised controlled trials are the foundation on 
which good practice guidelines have evolved. However, there are still limitations and 
disadvantages of this approach. In addition to the difficulties in observing and 
understanding human behaviour, Seaman & Verhonick (1982) point out that there 
are only a few valid criterion measures of the dependent variable available to indicate 
the effects of the independent variable upon human subjects. Additionally, in the 
current health service philosophy of encouraging participation in care i.e. fully 
informed consent and freedom of choice, some controlled experiments may 
increasingly seem both unacceptable and unethical.
Concerns have also been expressed by the nursing discipline over the fundamental 
issue regarding the suitability of scientific enquiry for investigating nursing 
interventions (Poole & Jones 1996). Consequently, experiments have often been 
deemed inappropriate for the advancement of nursing. Despite this, the field 
experiment is still considered to be a viable option for testing new techniques and 
procedures for nursing care (Wilson-Barnett 1991). The concise analysis of specific 
variables (techniques or treatment) under investigation is a key advantage of the 
experimental approach. The results from the analysis can then be used to determine 
the effects of nurse-led interventions on patient care.
It is evident from the literature reviewed in Chapter 2 that there is a paucity of 
experimental research investigating the effects of care provided by a DSN prescriber 
on in-patients with diabetes or its impact on outcome measures. This was an 
important fact that was considered during the formulation of the research questions 
and during the initial stages of the research design.
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4.4 Quasi-Experiments
The design of this research is a quasi-experiment. A true experiment consists of two 
equivalent groups of participants who are randomly assigned into either an 
experimental group or control group (Babbie 1998). In comparison to participants in 
the control group, those randomised to the experimental group are exposed to an 
intervention. However, in contrast to a true experiment, in a quasi-experimental 
design experimental and control groups may not be equivalent or randomized or 
there may be no control group (Polit et al. 2001).
Consequently, in a quasi experiment, as all the factors that might affect the outcome 
are not controlled, the researcher is more limited in drawing wider conclusions. 
Despite this, quasi-experiments are still associated with a high level of rigour (Polit et 
al. 2001). Consequently, the degree of confidence and level of causation which can 
be inferred from analysis of the data collected using this approach are also high.
In this study, which was conducted on six wards in one hospital in the East of 
England, it was neither possible nor practical to randomize the participants. A quasi- 
experimental design was chosen as a realistic and practical method to successfully 
evaluate the MMI. It enabled the intervention to be delivered without randomization, 
and prevented interaction between participants in the control and intervention groups 
(thus reducing the risk of bias within the results, and minimizing the rate of attrition).
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4.5 Study Design
A longitudinal study design was adopted. During the study there were three data 
collection points, on admission, discharge, and three months follow-up. The 
researcher, DSN prescriber and Consultant Diabetiologist agreed that a three month 
follow-up period was an appropriate time frame for patients to have recovered from 
their hospital admission and for the final data collection point.
Whilst it is accepted that the act of research and data collection (in itself an 
intervention) can affect the data (Becker et al. 2003), a time series involving the 
collection of data over an extended period of time allows data to be tested for change 
over time. As a result of participation however, during the period of data collection the 
testing effect can occur whereby participants improve their scores and or change 
their behaviour. Despite these limitations this was still deemed the most appropriate 
study design in order to assess the effect of the MMI provided by a DSN prescriber 
on the number of insulin and OHA medication errors, LOS, SE and patients’ medicine 
information needs.
Participants who met the inclusion criteria for the study (explained in more detail in 
section 4.7 of this chapter) and were recruited in the first three months were assigned 
to the control group (pre-intervention group). Following a one month period designed 
to enable ward staff to adjust to a nurse-led service, data was collected for a further 
three months. Subsequent participants who met the inclusion criteria, recruited 
between months 5-7, were then assigned to the intervention group. Participants in 
the control group received standard care i.e. their medicines were prescribed and 
managed by medical (i.e. House Officers, Senior House Officers and non-diabetes 
Specialist Registrars) and nursing staff other than a DSN prescriber. In comparison, 
participants in the intervention group, in addition to standard care, received the MMI
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delivered by the DSN prescriber (See chapter 3 and section 4.8 of this chapter for a 
more detailed description of the MMI). Figure 4.1 below provides a diagrammatic 
overview of the study design and the three data collection points used in the study.
Pre-intervention group 
Months 1-3:
All participants 
received routine care
Intervention group 
Months 5-7: All 
participants received 
Medicines Management 
Intervention
At DischargeOn Admission 3 month follow up
Figure 4.1: Study Design and Data Collection Points 
4.6 Research Setting
The research setting was six medical and surgical wards in a District General 
Hospital in the East of England. As part of a service improvement programme for in­
patients with diabetes, the Diabetes team at the hospital approached the University 
of Reading (the university where the researcher was registered as a student at the 
time) to undertake a collaborative study. This setting supported the quasi- 
experimental design of the study and allowed a detailed exploration and comparison 
of the delivery of two different models of care for in-patients with diabetes to be 
conducted.
Participants were recruited between May to December 2005 and data collection was 
completed in March 2006. The study wards were identified by the hospital as those 
where patients with diabetes were most likely to be admitted. Hospital staff including 
managers, consultants, the DSN and ward-based doctors and nurses confirmed that 
they would be willing to support the study.
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4.7 Sample Selection
Subjects were a convenience sample of patients with diabetes i.e. all patients 
admitted on to one of the six wards during the three month pre-intervention phase 
and three month intervention phase who met the inclusion criteria. Convenience 
sampling is the selection of the most readily available subjects as participants in a 
study (Polit et al. 2001). Although convenience sampling can limit generalizability and 
cause problems with representativeness, bias and erroneous findings, it is an 
inexpensive and efficient way of ensuring sufficient participants (Polit et al. 2001). 
The use of a convenience sample in this study ensured that all participants who met 
the inclusion criteria were in-patients with diabetes on one of the study wards at the 
hospital.
Data collected from all eligible patients admitted on to one of the six wards during the 
three month pre-intervention phase and three month intervention phase were 
specifically used to address question 1 (Sample 1) i.e. ‘do hospital in-patients, who 
receive a MMI from a DSN prescriber, experience a reduction in a) a the number of 
insulin and OHA medication errors and, b) LOS?’
Initial inclusion criteria were:
• Patients who were prescribed insulin and or OHA medication
• Patients who were not self-medicating
Figure 4.2 below provides a diagrammatic overview of the study design, sample 
selection and data collected from sample 1.
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Pre-Intervention
group
(Months 1-3)
Diabetic patient admitted to medicine, 
surgery, orthopaedic, vascular surgery, 
amputation or medicine (renal) ward
Intervention group
(Months 5-7)
Eligibility criteria checked
Not self-medicating 
Prescribed insulin and or oral 
hypoglycaemic medication
Months 1-3 
All participants 
received routine 
care
Eligible to participate?
C
 P a r t ic ip a n t  in  
Sample 1
Details added to study records 
(no further action taken)
Months 5-7 
All participants 
received Medicines 
Management
Data collected to answer Question 1:
Do hospital in-patients, who receive a medicines management 
intervention from a diabetes specialist nurse prescriber, experience a 
reduction in a) the number of insulin and oral hypoglycaemic (OHA) 
medication errors and, b) length of stav (LOS)?
On Admission
Collect demographic data: admission 
type, type and management of 
diabetes, age & sex
At Discharge
Admission and Discharge Date recorded, hospital 
medication chart, insulin chart, and insulin 
infusion chart copied made anonymous and sent 
for assessment of insulin and OHA errors
Data collection 
complete
Figure 4.2: Sample 1
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Additional inclusion criteria were then applied in order to generate a smaller sub­
sample of patients (Sample 2):
• does the patient have a predicted length of stay of at least 3 days (to 
ensure they were in hospital long enough to receive the MMI)?
• is the patient admitted to the medical ward (specialising in renal 
disease), the vascular surgery ward or the vascular amputation ward?
• is the patient conscious, alert and not confused, not acutely ill or in pain?
• does the patient have an adequate command of English?
• does the patient have any special needs or communication problems?
Patients who met the additional inclusion criteria were then approached on admission 
regarding willingness to participate in the additional elements of the study designed 
to answer question 2: ‘do hospital in-patients, who receive a MMI from a DSN 
prescriber, report improved levels of SE?’, question 3: ‘do hospital in-patients who 
receive a MMI report an improvement in the extent to which their medicine 
information needs are met?’ and question 4: ‘what types of information do patients 
consider important about their medicines?’ Figure 4.3 below provides a diagrammatic 
overview of the study design, sample selection and data collected from sample 2.
Prior to identifying the inclusion criteria for sample 2, the admissions department of 
the hospital were asked to provide data on the average length of stay for patients 
admitted to the six study wards. It became evident from this information that patients 
admitted to the renal medicine, vascular surgery and amputation wards were more 
likely to be admitted to hospital for at least three days i.e. long enough to receive the 
MMI. Therefore data for sample 2 were only collected from these three wards.
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Pre-intervention
group
M o n th s  1 -3 : All 
p artic ip an ts  re c e iv e d  
routine care
P a r t ic ip a n t  in 
Sample 1
Intervention group 
Months 5-7: All
participants received 
Medicines Management 
Intervention
Further eligibility criteria checked
Predicted length of stay at least 3 days?
Admitted to medicine (renal), vascular surgery or
vascular amputation ward
Conscious, alert and not confused
Adequate command of English
No special needs or communication problems
Eligible to
participate?
Yes
No Details added to studv records
Patient willing to participate & consent obtained?
Patient information leaflet given and left for 24 hrs
Yes No
Participant in 
Sample 2
Refusal recorded
At Discharge
Administer questionnaire 2
On Admission
Administer Questionnaire 1
Collect additional demographic data: marital status, employment, 
ethnicity, housing, length of diagnosis, other chronic disease
Additional Data collected to answer Questions 2, 3 & 4
Do hospital in-patients, who receive a medicines management intervention 
from a DSN prescriber, Q2) report improved levels of self-efficacy Q3) 
report an improvement in the extent to which their medicine information 
needs are met? Q4) What types of information do patients consider 
important about their medicines?
Normal care 
resumed
Figure 4.3: Sample 2
3 Month follow up
Administer questionnaire 3
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4.7.1 Sample size
Sample size was determined using the previous year’s admissions data from the six 
study wards and evidence from a review of medication error intervention studies 
(loannidis & Lau 2001). Reviewing data from 37 studies these researchers identified 
that regardless of sample size (range 90-11,000) large treatment effects were almost 
always present in the reviewed studies. An estimated sample size of 500 was 
therefore deemed adequate to ensure accurate and reliable statistical conclusions for 
sample 1.
Further consideration was given to determining the size of sample 2, and in order to 
answer research questions 2, 3 and 4. This was based on the information provided 
by the hospital admissions department described in section 4.8 and sample size 
(range 30-110) of the studies used in the psychometric testing of the diabetes 
management self-efficacy scale (DMSES) (Kappen et al. 2001, Kara et al. 2006, 
McDowell et al. 2005, Moens et al. 2001, van der Bijl et al. 1999); the scale used to 
measure diabetes self-efficacy described in Chapter 5.5.3. It was estimated that 
reasonable study effects would be detected if the size of sample 2 was around 80 
patients. However, an unexpected decrease in eligible patients admitted to the three 
relevant study wards during data collection, meant only 56 patients were recruited to 
sample 2.
4.8 Medicines Management Intervention
A DSN prescriber who was experienced and well regarded in the hospital was used 
to deliver the MMI to all patients in the intervention group. This included an initial 
patient assessment by the DSN prescriber (including a review of their medicines 
regime), one to three structured individual ward based patient education sessions 
appropriate to need (information was provided on the patient’s condition,
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management of medicines, medication changes and self-management), and on­
going review of patients medicines regime. Additionally, family members were 
included in the education sessions so they could also improve their knowledge and 
understanding of diabetes. The frequency of education sessions and their content 
were based on the initial patient assessment.
During the intervention period the DSN prescriber also provided medical and nursing 
staff with one to two individual education sessions appropriate to need. These 
sessions comprised information on the treatment regimes of each patient including 
drug action and dose, drug interactions and adverse effects. After discharge both 
groups of patients (i.e. pre-intervention and intervention) received routine care for 
their diabetes. Nurse supplementary prescribing was instigated in the absence of 
medical staff, in an emergency or if a delay in prescribing would adversely affect the 
patient.
4.9 Ethical Considerations
This research utilized the three primary ethical principles on which standards of 
ethical conduct in healthcare research are based: beneficence, respect for .human 
dignity, and justice (Hendrick 2000, Polit et al. 2001). These principles helped ensure 
that the rights of participants were protected and were used to guide each stage of 
the research process. Each ethical principle is discussed in more detail below:
a) Principle o f beneficence
Beneficence is the requirement to benefit the research participant. It is imperative 
that the researcher ensures that participants do not experience any harm 
(Hutchinson 2009). In this study, no risk was identified with regard to the physical, 
psychological or emotional involvement that could be caused by involvement in the 
study. In accordance with the NHS research and governance framework, data 
collected to answer research question 1 was classed by the Research Governance
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Committee at Peterborough and Stamford Hospital NHS Foundation Trust as an 
audit i.e. information was gathered with the intention of evaluating the effectiveness 
of efficiency of a care or treatment plan which lies within current professional practice 
(National Research Ethics Service 2006). This committee granted Research and 
Development approval for the study to be conducted in the hospital trust.
The study was also considered by the University of Reading Ethics Committee (the 
university where the researcher was registered as a student at the time) (a copy of 
the approval letter can be found in Appendix 1) who granted ethical approval for the 
study to be conducted.
b) Principle o f respect for human dignity
This principle includes the right to self-determination and the right to full disclosure. 
Self-determination means that participants have the right to decide voluntarily 
whether to participate in the study (Polit et al. 2001). As research question 1 was 
classed as an audit, only those participants who met the inclusion criteria for sample 
2 had the right to decide whether to take part in the additional element of the study 
i.e. completion of the three questionnaires.
Full disclosure means that the researcher has fully described the nature of the study, 
the person’s right to refuse participation, and the likely risks and benefits that would 
be incurred by the participant (Hutchinson 2009, Polit et al. 2001). This was achieved 
in the following way: on admission, all potentially eligible patients for sample 2 were 
approached and given an information sheet and contact details of the researcher 
(Appendix 2). The researcher returned at least 24 hours later and if the patient 
agreed to participate, full details of the study and required level of involvement were 
then provided. Time was spent with each potential participant answering questions
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and providing detailed information about the required level of involvement. A consent 
form (Appendix 3) was then signed by the patient and the researcher,
c) Principle o f justice
This principle requires the researcher to be fair to participants and maintain their right 
to privacy. This includes maintaining confidentiality and anonymity of data (Office of 
Public Sector Information 1998, Polit et al. 2001). In addition to the above 
procedures, and those described in more detail in chapter 5.3, the demographic 
details and medication charts used to extract data to answer research question 1 
were anonymised and coded in accordance with the Data Protection Act (1998).
The inclusion criteria, presented in section 4.7 of this chapter, ensured participants 
received fair treatment and a selection process based on the research requirements. 
The information sheet and consent form both emphasised the fact that completion of 
the questionnaires during the study was voluntary and participants could withdraw at 
any time if they wished to do so (Appendices 2 & 3). Patients were reassured that the 
study was anonymous and that no identifying information would be included in the 
report or publications emanating from the research. In case participants needed to 
access the researcher at any point during the study, each participant was given the 
contact details of the researcher.
The study was conducted in accordance with the approval of the University of 
Reading Ethics Committee and the Research Governance Committee at 
Peterborough and Stamford Hospital NHS Foundation Trust. The hospital also 
supported the researcher’s application to obtain an honorary research contract.
The following chapter explores the methods of data collection used in the study and 
analysis of data for each research question.
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Chapter 5: Methods 
5.1 Overview
This chapter explores the rationale for the methods of data collection and data 
analysis for each of the four research questions. It commences with a description of 
practicalities and access, and the use of documentary evidence to collect 
demographic data. The methods of data collection (i.e. retrospective case record 
review and questionnaires), tool development, methods used in the main study and 
analysis of data used for each research question are then considered.
5.2 Practicalities and Access
For an innovation or change in practice such as the MMI to be accepted, Lewin 
(1952) and Heifetz (1994) recommend that the process needs to be carefully planned 
and effectively communicated at each level of the organization. Additionally, it has 
been recognised that communicating clear role definitions and objectives is an 
essential part of the process which supports the effective implementation of specialist 
and advanced nursing roles (Lloyd Jones 2005).
In order to prepare the staff who worked in the hospital trust, a series of staff 
meetings were held prior to the pre-intervention phase at which details (including 
information sheets) about the research were disseminated. These meetings created 
an opportunity to improve doctors, nurses and senior hospital managers 
understanding about nurse prescribing and allowed them to discuss any concerns or 
queries they had about the MMI. All ward staff were invited to attend the meetings 
and also an additional meeting at which the interim findings would be presented. 
Medical staff and the senior management team of the hospital were also invited to a 
presentation of the interim findings. It was hoped that these interim meetings, as 
Kotter (1996) suggests, would provide an opportunity to provide feedback on the first
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stage of the project and help secure continued support from leaders of the 
organisation (i.e. senior management team). The researcher was also introduced to 
the medical and nursing staff on each ward and was provided with the opportunity to 
explain the research to staff in person.
Before and during the study regular meetings between the researcher, DSN 
prescriber and Service Improvement Manager were organised in London between 
September 2004 and January 2006. These meetings allowed discussion and support 
regarding the development and content of the research instruments, study design 
and progress of the study during data collection and analysis. Additionally, ongoing 
communication was maintained between the researcher, DSN prescriber and Service 
Improvement Manager through the use of regular e-mail and telephone contact.
5.3 Documentary Evidence
Documentary evidence, including both hospital and individual patient records were 
used to collect information on patients’ length of stay and demographic data. 
Documentary evidence is classed as any evidence (or document) which is used to 
extract data (Babbie 1998). A number of demographic variables of interest 
associated with diabetes related outcomes were identified from the literature 
including age, gender, type of diabetes, management of diabetes, duration of 
diabetes, co-morbidities, ethnicity, employment status and marital status (BMA 2004, 
Deakin etal. 2005, NCCCC 2008). Information extracted from these documents were 
used to support analysis of the data collected from the retrospective case record 
review and questionnaires, discussed in sections 5.4.6 and 5.5.7 of this chapter: 
detailed descriptions of which are provided in the following sections of this chapter.
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5.4 Q1: Do hospital in-patients, who receive a medicines management 
intervention from a DSN prescriber, experience a reduction in a) the 
number of insulin and OHA medication errors and, b) LOS?
5.4.1 Retrospective case record review
In order to collect data to answer research question 1a) a modified version of 
retrospective case record review was used. Although there are numerous 
approaches to collecting data on error events (including spontaneous voluntary 
reporting, solicited voluntary reporting, direct observation and computerized 
screening algorithms) (Karson & Bates 1999, Woloshynowych et al. 2003), 
retrospective case record review is a well established technique used to identify 
medication errors (Classen etal. 1997, Leape etal. 1991, Vincent etal. 2001, Wilson 
et al. 1995, Woloshynowych et al. 2003).
The basic methodology for this approach was developed in the early 1970s in the 
U.S for the Californian Insurance Feasibility Study (Woloshynowych et al. 2003). It is 
a two-stage process. During stage 1, medical records are screened according to 
predefined criteria (e.g. unexpected death, sepsis or unplanned returned to the 
operating theatre) in order to identify records of patients more likely to have suffered 
an adverse event. Records meeting one or more of the criteria are then forwarded for 
clinical review by a trained clinician i.e. stage 2. Each case record in the second 
stage is examined in detail to determine whether or not an adverse event has 
occurred and information about the nature and cause of the adverse event e.g. 
medical history and physiological measurements is extracted. An adverse event (AE) 
is an umbrella term used to describe errors in healthcare that patients experience. 
More specifically it is defined as ‘an unintended injury to patients which prolongs 
hospitalization or produces disability’ (Karson & Bates 1999).
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Retrospective case record review has a number of advantages (Vincent et al. 2001, 
Wilson et al. 1995, Woloshynowych et al. 2003). It provides a more complete 
indication of the incidence of AE than other types of reporting systems. The review 
documents provide a robust standardised method of recording and collecting data. 
However, the whole process is wholly dependent on the accuracy, completeness and 
legibility of patient records. Often the AE itself is not explicitly stated in the record and 
may not be recognised. Low to moderate inter-rater reliability has also been reported 
(Wilson et al. 1995). Furthermore, it can be time consuming and expensive. Despite 
these limitations however, several key studies have successfully used this method to 
improve patient safety and inform government policy (Classen et al. 1997, Vincent et 
al. 2001, Wilson et al. 1995, Woloshynowych et al. 2003).
Due to the time and financial limitations of this study, it was not possible or practical 
to review the full case records of each participant. A modified version of this 
technique was therefore adopted. An experienced and trained researcher in diabetes 
examined the anonymised medication records, insulin charts and sliding scale charts 
of all patients admitted onto the six study wards during the period of data collection. 
Each set of charts were assessed in order to determine whether or not the participant 
had experienced any insulin and OHA medication errors during their admission.
5.4.2 Tool development
In order to identify whether in-patients who receive a MMI from a DSN prescriber 
experienced a reduction in the number of insulin and OHA medication errors, a 
medication error chart (Appendix 4) was developed. Medication errors were identified 
from the literature (Kowiatek et al. 2001, Lesar et al. 1997, Manley et al. 2003), and 
work previously conducted in the study hospital (James 2003, 2004).
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Using the evidence from this literature, the errors were classified into fourteen 
different categories and reflected the three stages of the medication process targeted 
by the MMI i.e. prescribing, administration, and monitoring (Woloshynowych et a l
2003). Validity of the error categories was further confirmed by an expert panel 
based at the study hospital.
In order to support the reliability of the insulin and OHA errors that were recorded, the 
process by which errors were identified and extracted from the medication charts was 
conducted blind by an experienced diabetes researcher. Additionally, the first twenty 
error charts (and medication charts from which these errors were extracted), were 
reviewed blind by a Consultant Diabetiologist. There was agreement between the two 
reviewers (i.e. an experienced diabetes researcher and Consultant Diabetiologist) 
with regards to the insulin errors extracted from the medication charts and those 
recorded on the insulin and OHA medication error charts.
5.4.3 Pilot work
The medication error chart was piloted on the medication charts of twenty in-patients 
with diabetes i.e. insulin and OHA medication errors were extracted from the patient 
documents (i.e.. hospital medication chart, insulin and or insulin infusion chart) and 
recorded on the medication error chart. This process was undertaken to ensure that 
all errors identified in the patient documents would ‘fit’ within the categories described 
on the error chart and thus further validate the error categories. Although some minor 
refinements were made to the description of some error categories, it was evident 
that the format and content of the chart was appropriate.
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5.4.4 Methods used in Main Study
During the study, admission and discharge dates and demographic data (i.e. 
admission type, type and management of diabetes, age and sex) were collected from 
patient and hospital records on all participants. Following discharge, patient 
documents (i.e. hospital medication chart, insulin chart and insulin infusion chart) 
were assessed for the fourteen insulin and OHA medication errors i.e. errors were 
extracted from the patient documents and recorded on the error chart.
5.4.5 Recording and Organising Data
Microsoft Excel© was used to organise, collate and record the data from each 
patient. Upon discharge, in preparation for review and in order to maintain patient 
confidentiality and comply with the Data Protection Act (Office of Public Sector 
Information 1998), the hospital medication charts, insulin charts and / or the insulin 
infusion charts of each patient were photocopied and anonymised. These documents 
were then coded and the same code was given to the medication error chart used to 
record the fourteen insulin and OHA medication errors for each patient. In 
accordance with local policy and procedure, the photocopies and medication error 
charts (used to record the fourteen insulin and OHA medication errors) will be stored 
at the study hospital until 2016.
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5.4.6 Data analysis
Data were collected from a total of 452 participants (Sample 1). The basic 
demographic data collected for sample 1 supported a general analysis of the 
frequency and distribution of the fourteen insulin and OHA medication errors across 
the three stages of the medication process. More detailed demographic data were 
collected from the participants in the smaller sub-sample 2 (n=56) (see Chapter 4, 
Figure 4.1). This additional demographic information supported a separate and more 
detailed analysis and exploration between the frequency and distribution of the 
fourteen insulin and OHA medication errors and a number of additional variables e.g. 
marital status, employment status, ethnicity, length of time since diagnosis, 
accommodation and any other chronic disease or illness (see Appendix 5). These 
findings were then used to explore the relationship between insulin and OHA 
medication errors, SE and patients medicine information needs.
Microsoft Excel© and SPSS version 12 were used for data entry and data analysis. 
Descriptive statistics were used to describe the demographic nature of sample 1 and 
sample 2. To ensure that cell size reached the recommended minimum of five and in 
order to achieve a reasonable degree of statistical power to detect effect (Pallant 
2005), in both samples the fourteen insulin and OHA medication errors were re­
categorised into the three stages of the medication process (i.e. prescribing, 
administration, and monitoring). Median values for length of stay are presented as 
this not a normally distributed measure. For both samples chi-squared tests were 
used for categorical data when testing for association. A number of statistical 
procedures were then applied to each sample, the details of which are provided 
separately.
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A general linear modelling (GLM) procedure was used at various stages of the data 
analysis procedures for sample 1 and sample 2. GLM is a popular generalisation of 
the linear regression model, such that effects can be tested for categorical predictor 
variables e.g. type of diabetes and sex, as well as for effects of continuous predictor 
variables e.g. total number of errors and length of stay (Hill & Lewicki 2007). The 
GLM allows a wide variety of research outcomes to be summarized. Following 
discussion with a senior statistician from the University of Reading, this was deemed 
to be the most appropriate procedure to explore which if any demographic factors 
contributed significantly to explaining the variation in the total number of errors, 
length of stay and diabetes self-efficacy.
For each research question, and all tests that were conducted the level of 
significance (p-value) was set at the conventional 5% mark. Where findings fail to 
reach the level of statistical significance and / or are of particular interest they are 
included in the text.
Sample 1 data analysis
A GLM was used to explore whether age, sex, type of diabetes, admission category, 
or management of diabetes contributed significantly to explaining the variation in the 
total number of errors and length of stay. The model was then checked for goodness 
of fit using residual analysis.
Sample 2 data analysis
The number of categories for several variables (e.g. management of diabetes, marital 
status, accommodation and ethnicity) were reduced in order to achieve a reasonable 
degree of statistical power to detect effect (Pallant 2005).
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Independent-samples f-tests, a procedure used to establish whether the two means 
collected from the two groups differ significantly (Field 2005), were used to compare 
the total number of errors and total number of chronic diseases or illness between 
the pre-intervention and intervention group. A GLM procedure was used to explore 
which if any factors contributed significantly to explaining the variation in the total 
number of errors, the three stages of the medication process and length of stay. 
These factors included age, sex, type of diabetes, time since diagnosis, admission 
category, management of diabetes, employment, accommodation, having another 
chronic disease or illness. The model was then checked using residual analysis.
5.5 Q2: Do hospital in-patients, who receive a medicines management
intervention from a DSN prescriber, report improved levels of self- 
efficacy?
Q3: Do hospital in-patients, who receive a medicines management 
intervention from a DSN prescriber, report an improvement in the 
extent to which their medicine information needs are met?
Q4: What types of information do patients consider important 
about their medicines?
A series of three questionnaires were used to collect data in order to answer 
research questions 2, 3 and 4. A copy of each questionnaire is presented in 
Appendices 6, 7, 8. Data collection methods and analysis for these three research 
questions are considered together below.
5.5.1 Questionnaires
Whilst questionnaires are primarily used in survey research they are also widely used 
in experimental research (de Vaus 1996). There are three main approaches to using 
questionnaires; mail (self-completion), telephone surveys, and face to face 
interviews. Although the type of population, nature of question, and resources 
available will determine the type of questionnaire to be used, literacy problems,
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cognitive issues, language differences and cultural considerations need to be fully 
thought out with regards to each approach and adjusted for during questionnaire 
development (Beckett et al. 2000, Brener et al. 2003). Additionally, cost and 
manpower are other factors that will affect the choice of the distribution method. 
Consequently, before the questionnaire is designed, researchers need to satisfy 
themselves that the approach adopted will be the most effective for their study.
In order to ensure that the analysis is valuable and complete, questionnaires must be 
carefully and specifically designed. In addition to biased responses, poor 
questionnaire design will fail to provide accurate answers to the questions under 
investigation and produce much irrelevant information, wasting time and money 
(Bennett et al. 1994, Kelly & Long 2000, Oppenheim 2000). The layout of the 
questionnaire and format of questions therefore needs to be simple, clear and 
unambiguous. Furthermore, thought needs to be given to the questions asked, and 
how they will be interpreted.
Careful consideration was given to the design, format and layout of the 
questionnaires to ensure that the descriptive and analytic data generated would 
support appropriate analysis to answer the research questions. In order to generate 
good quality data sets, a combination of questionnaire approaches were used i.e. 
mail / self-completion and telephone.
1) Mail I self completion questionnaires
In a mail / self-completion questionnaire the respondent completes the questionnaire 
and the researcher has little control of the process. There are several advantages to 
this method. As the answers are anonymous, there is consequently less bias than in 
a face to face interview. Additionally, participants are able to consider their responses 
and take their time to complete it. However, there are some significant limitations.
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Whilst the nature, content and level of interest in the topic can affect the response 
rate, many postal questionnaires typically achieve only a 50% response rate (Babbie
1998). Poor response rates can cause problems with representativeness of the 
sample. However, this can be partially overcome by the use of reminder 
questionnaires. Incentives such as gifts, money or free samples, although not 
adopted in the current study, have also been shown to have a positive effect on the 
response rate (de Vaus 1996). Furthermore, there is no control over who completes 
the questionnaire or in what order, and the researcher is unable to probe and explore 
beyond the actual factual answer.
2) Telephone Questionnaires
Increasingly, telephones are being used as an approach to complete questionnaires 
(Smith 2005). Although the overall cost is similar to a mail survey, they are much 
quicker to complete and significantly improve the response rate (Smith 2005). The 
main advantage of this approach compared to mail / self-completion questionnaires 
is that the quality of data can be enhanced i.e. the researcher is able to develop a 
rapport with the participant and ensure the questions are understood. This can 
enhance the completion rate and quantity of data. However, given that concerns 
have been raised that responses may be shorter and less information may be 
divulged when this approach is adopted, it is important that interviewers ensure that 
they create an atmosphere of confidence and professionalism and reassure 
participants of their usefulness.
3) Questionnaires completed by Interviewers
When using interviews to complete a questionnaire the main issue surrounds 
standardization. Whilst visual interaction is unavoidable, interviewers need to be
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consistent in their approach and interaction with participants. As with telephone 
questionnaires, the researcher is able to develop a rapport and make sure the 
questions are understood by the participant. This approach also tends to yield a high 
response rate. However, compared to other approaches it is more costly in terms of 
both time and money.
The structure and format of the three questionnaires used in this study were based 
on the design of those previously used in the field of diabetes SE and patients 
medicines information needs (Berry etal. 2006, van der Bijl etal. 1999).
Participants in sample 2 were asked to complete three questionnaires. Questionnaire 
1 was given to participants following admission, questionnaire 2 at discharge and 
questionnaire 3 at three months follow-up. Questionnaire 1 and 2 adopted a self- 
complete approach (and were returned using a stamp-addressed envelope). 
Questionnaire 3 was completed by telephone. However, several patients (specifically 
those who were hard of hearing or had a breathing problem) chose to have the 
questionnaire mailed to them to complete.
5.5.2 Questionnaire structure and format
A set of three questionnaire booklets, each 4-6 pages in length, were developed for 
this part of the study. The first page of each questionnaire contained information 
about the study and simple instructions on how to complete the questionnaire.
Each questionnaire contained a series of fifteen 6-point Likert scale statements 
designed to assess diabetes SE, specifically participants’ confidence in activities to 
self-manage their diabetes i.e. managing blood sugar, adjusting medication, diet,
88
Chapter 5: Methods
exercise and lifestyle in various settings. Details of the next stage of the study were 
then provided.
Questionnaire 2 repeated the first fifteen questions and also included an additional 
question (Q16). The additional question asked participants to rate on a 6-point Likert 
scale how well their information needs had been met during their hospital stay. 
Questionnaire 3 comprised all questions in questionnaire 2, plus a series of eleven 
statements which required participants to rate how important certain areas of 
information were to them in an explanation about their medicines (Q17).
5.5.3 Questionnaire development
The questions used to assess diabetes SE and patients’ medicines information 
needs were developed using two previously well validated instruments (Berry et al. 
2006, van der Bijl et al. 1999). A description and rationale for the choice of these 
instruments is provided below.
All questions used unipolar Likert attitudinal scales to record responses and were 
graded from one to six, where six was the most positive response. Compared to 
single questionnaire items that capture the variable of interest, attitudinal scales 
provide the opportunity to view responses within the context of an individuals’ overall 
responses to scale items, thus minimising the possibility of misinterpretation (Howe 
1995). Responses obtained from individuals at different points in time are also more 
likely to be stable when using attitude scales compared to individual item indicators, 
thus enhancing reliability (Babbie 1998). However, it is important to note individuals 
who achieve the same overall score can respond very differently to particular items. 
Despite this limitation, attitudinal scales are an established and widely used 
technique (Howe 1995).
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1) Diabetes Self-efficacy tool
As discussed in Chapter 1, SE has been identified as both an important determinant 
of health behaviour and a good predictor of self care in chronic diseases (Bandura 
1977, Glanz et al. 1997, Holloway & Watson 2002, Marks et al. 2005a). The strength 
of SE expresses the strength of belief an individual has that they can attain the 
expected level of behaviour, whereas a lack of SE can be a perceived barrier to 
taking a recommended health action (O'Leary 1985). An individual may give up trying 
because they lack a sense of efficacy in achieving the required outcome. Ultimately, 
for a change in health behaviour to occur an individual must believe that the change 
will be beneficial, have belief in their ability to make the necessary change and that 
the change will result in a valued outcome. If the behaviour produces the desired 
outcome, the behaviour is more likely to be tried again (Bandura 1986, van der Bijl & 
Shortridge-Baggett 2001). Thus, adherence to difficult medical and / or lifestyle 
regimes are likely to be more consistent and longer lasting in those patients whose 
belief in their abilities to affect their health are strong (Bandura 1977, Clark & Dodge 
1999). Given that SE is a temporary and easy to influence characteristic (Clark & 
Dodge 1999), which is situation and task specific (Holloway & Watson 2002), the 
best way to assess SE is using a scale that has been designed to measure narrowly 
defined domains of SE in specific populations of patients with diabetes (Clark & 
Dodge 1999, Holloway & Watson 2002, van der Bijl & Shortridge-Baggett 2001).
A search of the literature between 1995-2005 identified five scales designed to 
assess diabetes related SE (Anderson et al. 2000, Rapley et al. 2003, Talbot et al. 
1997, van der Bijl et al. 1999, Weinger et al. 2005). During tool development each of 
the five scales was appraised with respect to content, appropriateness and 
psychometric properties. Overall suitability to support the design and answer the 
research questions in this study was also considered. It was evident from the
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literature (Anderson etal. 2000, Rapley et al. 2003, Talbot et al. 1997, van der Bijl et 
al. 1999, Weinger et al. 2005) that each scale has been designed to measure a 
variety of factors that affect diabetes SE including cognitive and social factors, 
psychosocial issues, diabetes knowledge, confidence, self-management and self- 
care behaviours.
Following this review the Diabetes Management SE scale (DMSES) (van der Bijl et 
al. 1999) was considered to be the most suitable scale and therefore selected. The 
DMSES is designed to measure efficacy expectations towards diabetes self-care 
activities, and has undergone extensive testing and validation. Additionally, a range 
of self-care behaviours are explored including general diabetes management, 
medication use, diet, self-monitoring of blood glucose (SMBG), exercise and foot 
care.
Five studies (Kappen et al. 2001, Kara et al. 2006, McDowell et al. 2005, Moens et 
al. 2001, van der Bijl et al. 1999) have been conducted to evaluate the DMSES scale 
in different populations and healthcare settings across the world. Convenience 
samples have been used to collect data from a total of 423 patients with diabetes 
from the community and hospital out-patient clinics. The twenty item DMSES has 
been adapted to four different languages, including English, and reported to be 
internally reliable in each setting. A more recently modified and validated fifteen item 
version of the DMSES (Sturt 2005) has also been developed. Good internal reliability 
of the DMSES (alpha coefficients ranging from 0.71-0.88) has been consistently 
demonstrated in studies that have previously explored the psychometric properties of 
the twenty item DMSES (Kappen et al. 2001, Kara et al. 2006, McDowell et al. 2005, 
Moens et al. 2001, van der Bijl et al. 1999). In addition, two studies which explored 
the longitudinal psychometric properties of the twenty item DMSES (Kara et al. 2006,
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van der Bijl et al. 1999) similarly reported satisfactory test-retest reliability / stability at 
four to five weeks (alpha coefficients 0.79-0.91 p<0.01).
The use of scales which focus on measuring different aspects of an attitude, as in the 
DMSES, reduces the possibility of misinterpretation based on a single item indicator 
and also enhances content validity (Babbie 1998). Satisfactory content and construct 
validity of the twenty item DMSES have previously been reported (Van der Bijl et al.
1999). As the intention in this study was to assess diabetes self-care activities and 
the self-management skills of patients with diabetes repeatedly, this was an 
important fact that was considered during the development phase of the 
questionnaire.
In order to measure diabetes SE in this study the DMSES was modified, whereby 
the number of ratings per each item of the fifteen point scale was reduced from ten to 
six. The modified version of the DMSES used in this study demonstrated good 
internal reliability at each stage of data collection (alpha coefficients ranging from 
0.79-0.92).
The content of the fifteen item SE scale, used as the first fifteen questions of each 
questionnaire can be found in Appendices 6, 7 & 8.
2) Medicines Information Needs tool
There is some evidence to suggest that giving patients information increases 
adherence to treatment regimes, increases self-care, self-management behaviour 
and promotes adaptive coping (Donovan & Blake 1992, Payne 2002). Berry et al. 
(1995) originally identified sixteen categories of information that individuals want to 
know about their medicine. Following a number of more recent studies (Berry et al.
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2006, Berry 2004, Berry et al. 2008, Berry et al. 1995, Berry et al. 1997), conducted 
to explore the medicine information needs of different groups of the population 
including members of the public, adults, young children and rheumatology out­
patients, the number of categories relating to the information needs of patients has 
been refined to eleven.
In this study, the eleven refined categories of medicine information (Berry et al. 
1995,1997, 2006, 2008) were used in questionnaire 3 (including information on side- 
effects, interactions, alternatives, and risks of not taking the medicine), in order to 
assess the medicine information needs of patients with diabetes (see Appendix 8, Q
17): the content validity and reliability of which are supported by their development, 
refinement and successful use in these more recent studies.
5.5.4 Pilot Work
In order to pilot the questionnaire ten patients with diabetes from Peterborough and 
Stamford Hospital NHS Foundation Trust (both hospital in- and out-patients) were 
asked to complete it. To further support the content validity, it was also sent to a 
DSN, hospital manager, and three academic colleagues specialising in diabetes. 
Participants in the pilot work were asked to comment on its ease of completion, and if 
they experienced any difficulties understanding what was required of them. Following 
this and comments from professional colleagues (DSN, manager and academic 
colleagues) the following amendments were made for the main study:
The length of questionnaire 1 was reduced by removing the section on demographic 
information. This information was then collected from the patient records. To reduce 
confusion all questions using Likert scales were graded from one to six, where six 
was the most positive response. In each questionnaire the instructions for
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participants, particularly the medicines information need categories (Q17) in 
questionnaire 3, were reworded to improve clarity. After further piloting of the revised 
instructions and questionnaires with three further in-patients with diabetes, the 
questionnaires were ready for dissemination in the main study.
5.5.5 Methods used in Main Study
It was anticipated that each questionnaire would take about ten minutes to complete. 
On admission questionnaire 1 was given to the participant with a stamped-addressed 
envelope (SAE) to the University of Reading. Participants were asked to complete 
the questionnaire in their own time and return it to the university using the SAE. 
Participants’ demographic information (including marital status, employment status, 
ethnicity, housing, other chronic disease or illness, and length of diagnosis and 
patient contact details) was collected from the patients’ records during hospital 
admission. Questionnaire 2 was distributed to patients upon discharge and 
participants were asked to return it to the university in the SAE provided.
A week before the final data collection point (three months after discharge), 
participants were contacted by telephone and asked if they were still willing to 
complete questionnaire 3. A convenient time and date was then arranged with 
participants to conduct the telephone interview. Each question on the questionnaire 
was read verbatim over the telephone and completed by the researcher. If a 
telephone number was not available, or participants preferred to self-complete the 
questionnaire, the questionnaire was mailed to them (Appendix 9), with a postal 
reminder (if not returned within 2 weeks) (Appendix 10). Thank-you letters were 
mailed to participants following completion of the final questionnaire (Appendix 11). 
All demographic information and data obtained from the questionnaires were 
anonymised, entered into a database and analysed. Each questionnaire was also
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coded. All the questionnaires are stored in a locked filing cabinet, secured against 
unauthorized access and will be kept at the University of Surrey until 2016.
5.5.6 Recording and Organising of Data
Microsoft Excel© was used to organise, collate and record the data from each 
patient. Consistent processing of the questionnaires was carried out and a clear 
record of the questionnaires returned by each participant was kept. Each participant 
was given the same number throughout the study to allow correlation between data 
on demographic information, insulin and OHA medication errors, SE and medicines 
information needs. A coding schedule was developed for each questionnaire and 
used during data entry.
5.5.7 Data Analysis
1) Self-efficacy
Microsoft Excel© and SPSS version 12 were used for data entry and analysis. Data 
were summarized using descriptive statistics. The maximum score for the series of 
fifteen statements used to assess SE in each questionnaire was 90 i.e. the higher the 
score the higher the level of SE. Independent-samples t-tests were conducted to 
compare SE at each data collection point between the pre-intervention and 
intervention groups. Paired samples t-tests were used to compare pairs of means for 
the SE scores. This was conducted to evaluate and compare the impact of the MMI 
on patients’ SE scores between groups.
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A GLM procedure was used to explore which if any factors contributed significantly to 
explaining the variation in the SE scores on the three questionnaires. These factors 
included age, sex, type of diabetes, employment, accommodation, and having 
another chronic disease or illness. The model was then checked using residual 
analysis.
The relationship between insulin and OHA medication errors, SE and data from the 
three patient questionnaires was also investigated using the Pearson product- 
moment correlation coefficient, a technique that is used to describe and explore the 
strength of the linear relationship between two variables (Pallant 2005). The Pearson 
correlation coefficient (r) can range from -1 to +1. The size of the value provides 
information on the strength of the relationship, where a correlation of zero indicates 
no relationship between the two values. Relationships investigated included sex, type 
of admission, type of diabetes, length of stay, total number of errors.
2) Patient information needs and Types of medicine information
Data collected via Likert scales are ordinal (Mogey 1999) i.e. they have an inherent 
order, but it cannot be assumed that the difference between the points on the scales 
are the same. Data collected via Likert Scales were therefore summarized using 
descriptive statistics, and the distribution of observations displayed with tables. The 
frequency of responses was examined by combining the number of people selecting 
1 or 2, and 5 or 6, scores. The non-parametric Mann-Whitney test, which works on 
the basis of ranking (Mogey 1999), was used to compare the findings between the 
two groups.
The next chapter presents the findings from the analysis of data, which are presented 
under each of the four research questions.
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Chapter 6: Results
6.1 Overview
The results represent the analysis of the data collected from the documentary evidence, 
modified retrospective case record review and three questionnaires. An initial descriptive 
overview of participants will be followed by examination of the variables in relation to the 
effect of the medicines management intervention on medication errors, length of stay, self- 
efficacy, the extent to which patients’ information needs were met, and in determining what 
information patients consider to be important about their medicines. The results are 
described below under each of the four research questions.
6.2 Q1: Do hospital in-patients, who receive a medicines management 
intervention from a DSN prescriber, experience a reduction in a) the 
number of insulin and OHA medication errors and, b) LOS?
Data collected from the modified retrospective case record review and documentary 
evidence (i.e. demographic information and information on LOS) are presented below. The 
results from sample 1 and the smaller sub-sample 2 are presented separately.
6.2.1 Sample 1
Between May 2005 and December 2005, 452 patients were included in sample 1 across 
both the pre-intervention (n=187) and intervention (n=265) groups using the inclusion 
criteria described in Chapter 4.7. The basic demographic data collected supported a 
general exploration and analysis of several key variables associated with diabetes patient 
outcomes and the frequency and distribution of the fourteen insulin and OHA medication 
errors.
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6.2.2 Sample 1: Demographic Data
Table 6.1 summarises the demographic data collected from patients across sample 1. 
Participants were male (n=258) and female (n=194), and were admitted under medicine 
(n=227), surgery (n=98), kidney disease (n=27), orthopaedics (n=52), vascular amputation 
(n=17) and vascular surgery no amputation (n=31). Over 75% of participants across the 
two groups had type 2 diabetes and over 55% were treated with insulin. Patients’ age 
ranged between 18-93 years and over 30% were more than 75 years of age.
Table 6.1: Sample 1: Patient characteristics
Chi square test Pre-intervention
(n=187)
Intervention
(n=265)
P value
Type of Diabetes n % P= 0.980
Type 1 44 23.9% 60 23.3%
Type 2 140 76.1% 197 76.8%
Sex P= 0.690
Male 106 56.7% 152 57.4%
Female 81 43.3% 112 42.3%
Management of Diabetes P=0.771
Oral hypoglycaemic agents 79 44.9% 109 43.4%
Insulin 63 35.8% 98 39%
Oral hypoglycaemic agents and 
Insulin
34 19.3% 44 17.5%
Type of Admission P=0.021
Medicine 83 44.4% 144 54.3%
Surgery 41 21.9% 57 21.5%
Kidney disease 11 5.9% 16 6.0%
Orthopaedics 21 11.2% 31 11.7%
Vascular amputation 12 6.4% 5 1.9%
Vascular surgery (no amputation) 19 10.2% 12 4.5%
Age P=0.197
<=61 years 64 34.2% 100 38.5%
62-74 years 63 33.7% 77 29.6%
> 75 years 60 32.1% 83 31.9%
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In order to rule out patient demographic influences upon study results, all baseline 
demographic variables were examined to check for parity between the pre-intervention 
and intervention groups. Patient characteristics across the two study groups were 
generally similar (Table 6.1), although a greater proportion of patients in the intervention 
group were treated with insulin, were aged less than 61 years and admitted under 
medicine. Results of chi-square analysis showed that there was a significant difference in 
admission category between the two groups: however, there were no significant 
differences in the other demographic characteristics i.e. sex, age, type of diabetes, and 
management of diabetes.
6.2.3 Sample 1: Insulin and OHA Medication Errors
Data relating to the frequency and distribution of the fourteen insulin and OHA medication 
errors across the three stages of the medication process experienced by patients in 
sample 1 are presented in this section. Findings comparing the frequency of errors in the 
pre-intervention and intervention groups, and at each stage of the medication process are 
then presented.
In total, insulin and OHA medication errors were recorded for 85.8% (n=388) of patients 
across both the pre-intervention and intervention groups (see Table 6.2). Some patients in 
both groups experienced multiple errors. The maximum number of errors recorded for one 
patient in the pre-intervention group was 130 compared to a maximum of 33 errors for a 
patient in the intervention group. Administration (42%) and prescribing errors (43%) were 
the most frequent categories of ME on the charts of participants in both groups. Nurse 
Supplementary prescribing i.e. medicines were prescribed using an agreed clinical 
management plan (as described in Chapter 1.2), was initiated for 30 patients.
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It was evident from an independent-samples f-test that there was a significant reduction in 
the total number of errors between pre-intervention (M=13.4, SD=21) and intervention 
groups (M=3, SD=6.0; t(376)=7.45, p=0.00). The magnitude of the differences in the 
means was moderate (efa-squared=0.11). Patients in the pre-intervention group 
experienced on average more than four times as many errors as those in the intervention 
group.
(The 7-statistic is the statistic that is used to test whether a regression co-efficient is 
significantly different from zero, in this case used to determine whether the differences 
between two means are significantly different from zero (Field, 2005). Eta squared, can 
range from 0 to1, and represents the proportion of variance in the dependent variable that 
is explained by the independent (group) variable (Pallant, 2005).)
Table 6.2: Sample 1: Insulin and OHA medication errors
Type of Insulin & OHA Medication Error Pre-
Intervention
Intervention Difference Reduction
Administration
errors
Insulin doses not signed as given 410 207 -203
Inappropriate dose of short acting insulin 
administered in response to hyperglycaemia
91 9 -82
OHA medication not signed as given 53 28 -25
Sliding scale doses not signed as given. 45 70 +25
Omission of insulin after hypoglycemia 16 8 -8
Charts incomplete 9 7 -2
Total Administration errors 624 (40%) 329 (44%) -295 -47%
Prescribing
errors
Name of insulin incorrect 247 82 -165
Insulin chart not signed by prescriber 108 44 -64
Unit abbreviated to ‘u’ and unclear 89 113 +24
Insulin not written up 62 60 -2
Number of units of dose unclear 52 56 +4
Prescription chart not signed by prescriber 11 11 0
Total Prescribing errors 569 (36%) 366 (49%) -203 -36%
Monitoring
errors
Insulin/oral medication dose not adjusted 
when persistent BG>14mmols
246 45 -201
Insulin/oral medication dose not adjusted with 
persistent BG <4mmol
134 14 -120
Total Monitoring errors 380 (24%) 59 (8%) -321 -85%
Sum of Total errors 1573 (100%) 754
(100%)
-819 -52% |
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Using an independent-samples f-test it was also evident that there was a significant 
reduction and difference in the total number of errors between the two groups at each of 
the three stages of the medication process targeted by the MMI (p<0.05). Patients in the 
pre-intervention group experienced more than twice as many administration, prescribing 
and monitoring errors as those in the intervention group (see Table 6.3). The frequency of 
monitoring errors was reduced by 85% in the intervention group.
Table 6.3: Sample 1: Group comparison of insulin and OHA medication errors at 
each stage of the medication process
Pre-Intervention 
Mean & SD
Intervention 
Mean & SD
df t P value Eta2
Administration errors M=3.5, SD=9 M=1.3, SD=3.35 449 2.81 0.006 0.02
Prescribing errors M=2.9, SD=9 M=1.4, SD=3.0 448 2.20 0.028 0.01
Monitoring errors M=1.91, SD=8 M=0.2, SD=1.32 449 3.11 0.002 0.02
(Degrees of freedom (df) is defined as the number of independent observations in a 
sample of data that are available to estimate a parameter of the population from which that 
sample is drawn (Field 2005).)
6.2.4 Sample 1: Effect of admission category and group on insulin and OHA 
medication errors
In order to determine if any of the baseline demographic variables (i.e. age, sex, type of 
diabetes and admission category) contributed significantly to explaining the variation in the 
total number of errors, a general linear modelling (GLM) procedure (as described in 
chapter 5.4.6) was conducted.
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Admission category was found to influence the number of errors patients experienced with 
the average number of errors varying across each admission category. Patients in the pre­
intervention group admitted to the vascular amputation ward experienced nearly ten times 
as many errors as those in the intervention group (see Table 6.4).
Table 6.4: Sample 1: Effect of admission category and group on insulin and OHA 
medication errors
Orthopaedic
Admission
Category Sursery 
Medicine
Kidney disease
Vascular surgery {no 4  3
amputation) 1 0 . 2
3 n
Vascular amputation ? r |  ^  ■ ,, 29 5
0 10 20 30 40
Mean number of errors
Using a GLM, it was apparent that the total number of errors was significantly affected by 
both group and admission type (p=0.000) (see Table 6.5). In the pre-intervention group 
patients admitted to the vascular amputation ward experienced the greatest number of 
errors. By contrast, patients in the intervention group admitted to the vascular surgery 
ward experienced the greatest number of errors.
■ Intervention
■ Pre-intervention
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Table 6.5: Sample 1: GLM: Effect of admission category and group on 
insulin and OHA medication errors
Admission Orthopaedic
Category
Kidney disease 
Medicine 
Surgery
Vascular surgery {no amputation)
Vascular amputation
0 10 20 30 40
Adjusted mean number of errors
6.2.5 Sample 1: Length of Stay
In the pre-intervention group the median length of stay was 9 days (inter-quartile range 4-
18) compared to a median of 7 days (inter quartile range 4-13) in the intervention group 
(p<0.05). A GLM procedure identified that LOS was significantly affected by both group 
and admission type (p=0.000). Patients in the pre-intervention group admitted to the 
vascular amputation ward had the longest length of stay (see Table 6.6)
■ Intervention
■ Pre- Intervention
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Table 6.6 Sample 1: Effect of admission category and group on length of stay
Orthopaedic
Admission
Category Kidney disease
Medicine 
Surgery
Vascular surgery {no amputation)
Vascular amputation
0 20 40 60 80
Adjusted mean length of stay
The Pearson product-moment correlation technique was used to explore the relationship 
between LOS, total number of errors, age and sex in more detail. A medium, positive 
correlation was found to exist between the length of stay and the total number of errors in 
the pre-intervention group [r=0.43, n=107, p<0.01]. As the total number of errors 
increased, so did length of stay. Although this effect was also present in the intervention 
group, it was less marked [r=0.196, n=246, p<0.01]. There was no correlation between 
length of stay and age or sex.
6.2.7 Sample 2
After applying the further inclusion criteria, described in chapter 4.7, fifty six patients were 
recruited to sample 2 across both the pre-intervention (n=27) and intervention (n=29) 
groups between May 2005 and December 2005.
■ Intervention
■ Pre Intervention
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6.2.8 Sample 2: Demographic Data
Table 6.7 summarises the demographic data collected across both the pre-intervention 
(n=27) and intervention (n=29) groups. Participants were male (n=35) and female (n=21), 
and were admitted under both medicine (specialising in renal disease) and surgery 
(including vascular amputation and vascular surgery). The majority of participants (over 
75%) across the two groups had type 2 diabetes and over 50% were treated with insulin. 
Patients’ age ranged from 26 to 81 years and 55.6% had been diagnosed with diabetes for 
less than fifteen years.
All baseline demographic variables were examined to check for parity between the pre­
intervention and intervention groups in order to rule out patient demographic influences 
upon study results. Patient characteristics in the pre-intervention and intervention groups 
were generally similar (Table 6.7), although there is evidence that a greater proportion of 
patients in the pre-intervention group were treated with insulin, had been diagnosed with 
diabetes for more than fifteen years, and had another chronic disease. By contrast, a 
greater proportion of patients in the intervention group was admitted to the medical ward, 
and aged less than 70 years. However results of chi square analysis showed that although 
there was a significant difference in the type of admission between the two groups, there 
were no significant differences in the other demographic characteristics i.e. sex, age, type 
of diabetes, management of diabetes, ethnicity, employment status, marital status, 
accommodation and chronic diseases.
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Table 6.7: Sample 2: Patient characteristics
Chi square test Pre-intervention
(n=27)
Intervention
(n=29)
P value
Type of Diabetes n % n % P=1.00
Type 1 5 18.5% 5 17.2%
Type 2 19 70.4% 23 79.2%
Sex P=0.836
Male 16 59.3% 19 65.5%
Female 11 40.7% 10 34.5%
Management of Diabetes P=0.206
Oral hypoglycaemic agents 10 37% 10 34.5%
Insulin/ oral hypoglycaemic agents 
& Insulin only
14 51.9% 15 51.7%
Type of Admission P=0.02
Medicine 9 33.3% 19 65.5%
Surgery L  17 63.7% 8 27.6%
Age P=0.254
< 50 years ^ 3 11.1% 6 20.7%
51-69 years 11 40.7% 15 51.7%
>70 years 13 48.2% 8 27.6%
Marital status P=1.00
Married/living together 12 44.4% 13 44.8%
Divorced/separate/single/widowed 15 55.6% 16 55.2%
Employment P=0.883
Not employed 20 74.1% 23 79%
Employed 7 25.9% 6 20.7%
Ethnicity P=0.587
White 25 92.6% 28 96.6%
Asian/Black/ British Asian/British 
Black
2 7.4% 1 3.4%
How long since diagnosed? P=0.300
0-15 years 15 55.6% 21 72.4%
> 15 years 12 44.4% 8 27.6%
Other chronic disease/illness P= 0.589
No 10 37% 5 17.2%
Yes 17 74% 24 82.8%
Accommodation P=0.217
Detached or semi detached house 23 85.2% 20 71.4%
Terrace or flat 4 14.8% 8 28.6%
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6.2.9 Sample 2: Insulin and OHA Medication Errors
A comparison of the frequency and distribution of the fourteen insulin and OHA medication 
errors between the pre-intervention and intervention groups of sample, and at each stage 
of the medication process is presented in this section.
Across both the intervention and pre-intervention groups, ME were recorded for forty two 
(75%) patients (see Table 6.8), many of whom experienced multiple errors. Administration 
(56%) and prescribing errors (44%) were the most frequent type of ME present on the 
charts of participants across both groups. Nurse supplementary prescribing was used to 
prescribe medicines for seven patients.
Table 6.8: Sample 2: Insulin and OHA medication errors
Type of Insulin & OHA Medication Error Pre-
Intervention
Intervention Difference Reduction
Administration
errors
Insulin doses not signed as given 255 63 -192
Inappropriate dose of short acting insulin 
administered in response to hyperglycaemia
10 0 -10
OHA medication not signed as given 7 3 -4
Sliding scale doses not signed as given. 9 3 -6
Omission of Insulin after hypoglycemia 10 1 -9
Charts incomplete 1 2 -1
Total Administration errors 292 (56%) 72 (48%) - 2 2 0 -76%
Prescribing
errors
Name of insulin incorrect 60 18 -42
Insulin chart not signed by prescriber 70 7 -63
Unit abbreviated to ‘u’ and unclear 27 34 +7
Insulin not written up 14 5 -9
Number of units of dose unclear 25 6 -19
Prescription chart not signed by prescriber 3 0 -3
Total Prescribing errors 199 (38%) 70 (49%) -129 -64%
Monitoring
errors
Insulin/oral medication dose not adjusted 
when persistent BG>14mmols
0 0 0
Insulin/oral medication dose not adjusted with 
persistent BG <4mmol
29 5 -24
Total Monitoring errors 29 (6 %) 5 (3%) -24 -83%
Sum o f Total errors 520
(1 0 0 %)
147
(1 0 0 %)
-373 -72%
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It was evident from an independent-samples Mest that there was a significant reduction in 
the total number of errors between pre-intervention (M=26, SD=35.04) and intervention 
groups (M=5.03, SD=7.79; t (47)=2.632 , p=0.016). The magnitude of the differences in 
the means was moderate (efa-squared=0.11). A mean reduction of 21 errors was 
identified in the intervention group.
Using an independent-samples Mest, it was evident that there was a reduction in the 
average number of errors at each of the three stages of the medication process targeted 
by the MMI. Patients in the pre-intervention group experienced more than four times as 
many administration errors as those in the intervention group (p=0.05) (see Table 6.9). 
Administration and monitoring errors were both reduced by more than 75% in the 
intervention group.
Table 6.9: Sample 2: Group comparison of insulin and OHA medication errors at 
each stage of the medication process
Pre-intervention 
Mean & SD
Intervention 
Mean & SD
df t P value
Administration errors M=11.2, SD=20.9 M=2.5, SD=4.89 53 2.09 0.05
Prescribing errors M=7.65, SD=13.2 M=2.4, SD=4.1 53 1.95 0.06
Monitoring errors M=1.12, SD=2.9 M=0.17, SD=0.66 53 1.60 0.12
6.2.10 Sample 2: Effect of admission category on the number of insulin and OHA 
medication errors
In order to determine if any of the baseline demographic variables (i.e. age, sex, type of 
diabetes and admission category) contributed significantly to explaining the variation in the 
total number of errors, a GLM procedure was conducted.
The number of errors patients experienced was found to be affected by whether they had 
been admitted as part of the pre-intervention or intervention group. Patients in the pre­
intervention group experienced up to three times as many errors as those in the 
intervention group (see Table 6.10).
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Table 6.10: Sample 2: Effect of admission category and group on insulin and OHA 
medication errors
mean number 
of errors
40
35
9.830
25
20
15
26.7
10 3.6
5 7.3
0
MedicineSurgery
■ Intervention
■ Pre Intervention
Admission Category
Using a GLM, admission category was identified as being a key factor (p=0.06) 
contributing to the variation in the total number of errors. Although admission category did 
not significantly affect the number of errors, patients who had been admitted to the 
surgical wards in both the pre-intervention and intervention group experienced more errors 
compared to those patients admitted to the medical ward (see Table 6.11).
Table 6.11: Sample 2: GLM: Effect of admission category and group on insulin and 
OHA medication errors
Adjusted mean 
number of 
errors
50
45
40
35
30
25
20
15
10
5
0
35
Surgery Medicine
Admission Category
■ Intervention
■ Pre Intervention
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6.2.11 Sample 2: Length of stay
In the pre-intervention group the median length of stay was 17.5 days (inter-quartile range 
10-46), compared to median of 14.5 days (inter-quartile range 9-32) in the intervention 
group (p<0.05).
In order to determine if any of the baseline demographic variables (i.e. age, sex, type of 
diabetes and admission category) contributed significantly to explaining the variation in 
length of stay a GLM was performed. Using a GLM it was apparent that although 
admission type contributed to length of stay, this was not at a significant level (p=0.42). 
Patients admitted to the surgical wards in the pre-intervention group experienced an 
adjusted mean length of stay which was more than double that of patients admitted to the 
medical wards (see Table 6.12). In order to explore the extremely large difference 
between LOS and admission type in the pre-intervention group, a further independent 
sample f-test was conducted. It was evident from the results that admission type had a 
highly significant effect on LOS for this group of patients (p=0.0004).
Table 6.12: Sample 2: Effect of admission category and group on length of stay
Admission
Category
Medicine
■ Intervention
■ Pre-intervention
Surgery
Adjusted mean length of stay
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6.4 Q2: Do hospital in-patients, who receive a medicines management
intervention from a DSN prescriber, report improved levels of self- 
efficacy?
Across the pre-intervention and intervention group 100% of participants (n=56) completed 
and returned the first questionnaire. Four patients died prior to completing the second 
questionnaire and a further seven did not return this questionnaire. In total 45 participants 
(80%) returned the second questionnaire. The third questionnaire was completed by 41 
participants (73%); two postal questionnaires were not returned and the remaining two 
patients were readmitted to hospital. The overall completion rate for the three 
questionnaires was 84%.
Data collected from the first 15 questions of all three questionnaires, designed to assess 
diabetes SE, are presented below.
Participants completing questionnaires on admission and at three month follow-up, in both 
the pre-intervention and intervention groups, reported similar SE scores. At discharge, 
participants in the intervention group scored on average nine more points compared to 
those in the pre-intervention group (see Table 6.13). Results of independent samples t- 
tests confirmed that there was no significant difference in the SE scores on admission 
(SE1), discharge (SE2) or at three month follow-up (SE3) between the intervention and 
pre-intervention groups (see Table 6.13).
Table 6.13: Group comparison between self-efficacy on admission, 
discharge and three month follow-up
Independent 
samples t- 
test
Pre-intervention 
Mean & SD
Intervention 
Mean & SD
df t P value
SE1 M=68, SD=18.2 M=70, SD=15.4 54 -0.445 0.66
SE2 M=62, SD=17.7 M=71, SD=14 42 -1.731 0.091
SE3 M=76, SD=8.4 M=73, SD=11.1 39 0.872 0.386
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In order to determine what if any effect the MMI had on SE, the SE scores reported by 
participants at each of the three data collection points in the pre-intervention and 
intervention groups were explored using paired samples Wests (see Table 6.14). In the 
pre-intervention group a large significant increase (p=0.02) in SE was identified between 
discharge and at three month follow-up (See Table 6.14) i.e. a mean increase of fourteen 
points was identified in participants in the pre-intervention group who completed the three 
month follow-up questionnaire (see Table 6.13).
Table 6.14: Impact of the medicines management intervention on self-efficacy
Paired-samples f test Pre-Intervention Intervention
df t P value df t P value
SE1-SE2 21 0.987 0.34 21 -0.34 0.97
SE2- SE3 15 -2.548 0.02 15 0.258 0.80
SE1-SE3 19 -2.006 0.06 20 -0.39 0.70
6.4.1 Factors affecting self-efficacy
A GLM was conducted in order to determine if any of the baseline demographic variables 
(i.e. age, sex, type of diabetes and admission category) contributed significantly to 
explaining the variation within each SE. Type of diabetes was found to contribute to the 
variation of SE scores. Patients with type 2 diabetes in both the pre-intervention and 
intervention group had lower levels of SE at discharge than patients with type 1 diabetes 
(p=0.04) (see Table 6.15).
Table 6.16: Effect of type of diabetes and group on self-efficacy at discharge
Type 2 Diabetes 
Type 1 Diabetes U R B lM H i
In te rven tio n  
Pre In terven tio n
) 50  100
Adjusted m ean SE score at discharge
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The Pearson product-moment correlation technique was used to explore the relationship 
between SE, length of stay, total number of errors, patients’ characteristics and 
demographic information in more detail.
Across both groups, a number of significant relationships were identified between SE, 
insulin and OHA medication errors, patients’ characteristics and demographic information. 
In the pre-intervention group significant negative correlations were identified between SE2, 
age and admission category. Lower levels of SE were associated with older patients [r=- 
0.46, n=0.34 p=0.034], and patients admitted under the surgical ward [r=-0.43, n=21 
p=0.05]. Similarly, a significant negative correlation was identified in the intervention group 
between SE2 and the total number of errors. Lower levels of SE were associated with 
patients who experienced a higher number of insulin and OHA medication errors [r=-0.44, 
n=22, p=0.039].
113
Chapter 6: Results
6.5 Q3: Do hospital in-patients, who receive a medicines management
intervention from a DSN prescriber, report an improvement in the 
extent to which their medicine information needs are met?
Data collected from question 16 in questionnaires 2 and 3 were used to determine whether 
patients who receive a MMI from a DSN prescriber report an improvement in the extent to 
which their medicine information needs are met.
Overall, 69% of participants reported that their information needs had been met (Table 
6.16) and the overall median was 5.5 (inter-quartile range 3-6) (Table 6.17). Two people 
(7%) in the pre-intervention group indicated that their information needs had not been met. 
At three month follow-up, 77% of all participants reported that their information needs had 
been met compared to only 61% at discharge (Table 6.16).
Table 6.16: To what extent have your information needs been met?
n
Pre-intervention Intervention
Needs not met Needs totally 
met
Needs not met Needs totally 
met
1 & 2 5 & 6 1 & 2 5 & 6
Count % Count % n Count % Count %
Discharge 14 1 7.1 8 57 16 0 0 11 65
Three month 
follow-up
6 1 6 14 82 18 0 0 13 72
114
Chapter 6: Results
There was no significant difference between the pre-intervention or intervention group in 
the number of people whose information needs had been met (p=0.50-056) (Table 6.17).
Table 6.17: Group comparison showing median, inter-quartile range & Mann- 
Whitney test
Pre-intervention Intervention
Median Inter-quartile
range
Median Inter-quartile
range
Mann-Whitney Test 
: z & p values
Discharge 5 3-6 5 3-6 z= -0.76 p=0.50
Three month follow-up 6 __ 5-6 6 5-6 z=-0.59 p=0.56
6.6. Q4: What types of information do patients consider important about
their medicines?
Data collected from question 17 in questionnaire 3 were used to determine what types of 
information patients consider to be important about their medicines. Participants were 
asked to rate how important eleven areas of information were to them in an explanation 
about their medicines (1 indicated ‘not at all important’ and 6, ‘very important’). In both the 
pre-intervention and intervention group at least 75% of participants rated all eleven types 
of information highly (see Table 6.18). The overall median was 6 (inter-quartile range 5.25- 
6) (See Table 6.20). Results from the Mann-Whitney test confirm that overall participants, 
in both the pre-intervention and intervention groups, reported very similar levels of 
importance to the eleven types of information (range of p=0.3-1.00) (see Table 6.20).
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Table 6.18: Importance of the different types of medicines information
n=40 unless otherw ise stated Not at all /not 
important
Important/ very 
important
1 & 2 5 & 6
Count % Count %
1. What the medication is (drug type etc) 0 0 36 90
2. What the medication does / how it works 0 0 35 88
3. Probability medicine will be effective 2 5 36 90
4. Detailed questions about taking medicine (e.g. dosage) 0 0 37 98
5. Possible side effects 1 2.5 35 88
6. Interactions with other medicines 1 2.5 35 88
7. Any alternatives to medication 4 10 30 75
8. What to do if you forget to take it or take too much (n=39) 1 2.5 36 92
9. How will you know if medication is working (n=38) 0 0 35 84
10. Risks of not taking medication (n=38) 1 2.5 32 84
11. How to contact the nurse/doctor (n=38) 0 0 36 95
Participants reported that the most important types of information were: detailed questions 
about the medicine (e.g. dose) (98%), how to contact the nurse/doctor (95%) and what to 
do if  you forget (92%), followed by what the medication is (drug type etc.) and probability 
o f the medicine being effective (each 90%). Information on what the medication does /  
how it works, possible side effects, and interactions, how to know if  the medicine is 
working and risks o f not taking the medicine and alternatives to medicines were found to 
be less important to participants (see Tables 6.18 & 6.19).
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Table 6.19: Information that is important and very important to patients 
about their medicines
Information that is important/very important to patients about their
medicine by group
□ Pre-lnter\ention □ Intervention
fc*oo
3reO
co+3
E
£ 4 c
11. How to contact the nurse/doctor 
10. Risks of not taking medication 
9. How will you know if medication is working 
8. What to do if you forget to take it or take too much 
7. Any alternatives to medication 
6. Interactions with other medicines 
5. Possible side effects 
Detailed questions about taking medicine (e.g. dosage) 
3. Probability medicine will be effective 
2. What the medication does / how it works 
1. What the medication is (drug type etc)
1
__ p.
- I - I I = F
20 40 60 80
% of participants
100 120
Participants in both the pre-intervention and intervention group rated three areas 
(probability medicine will work, detailed questions about taking medicine and risks o f not 
taking the medicine) as very important (median=6, inter-quartile range 5.75-6). Overall, 
participants rated alternatives to medication as the area of information that is least 
important to them (median=6, inter-quartile range 4-6) (see Table 6.20).
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6.6 Summary
This chapter presents data from the documentary evidence and modified retrospective 
case record review collected from the 452 participants of sample 1, fifty six participants of 
sample 2, and the three questionnaires also completed by sample 2. All participants were 
admitted to one of the six study wards of a district general hospital in the East of England 
between May and December 2005.
Patient characteristics in the pre-intervention and intervention groups of both sample 1 and 
sample 2 were generally similar. The majority of participants were diagnosed with type 2 
diabetes and admitted to the medical ward. In both samples, there was a statistical 
difference in admission category between the two groups (p<0.05). However, there were 
no statistical differences in the other demographic variables i.e. age, sex, type of diabetes 
or management of diabetes.
In both samples, participants who received the MMI experienced significantly fewer insulin 
and OHA medication errors (p<0.001 & p<0.05 respectively). Errors were reduced at each 
of the three stages of the medication process targeted by the intervention, and in sample 1 
these reductions were at level of statistical significance (p<0.05). In both samples, the 
majority of errors (42% and 56% respectively) occurred during the administration process 
by which patients received their medicines. Median length of stay was less for patients in 
the intervention group (by two days in sample 1, and three days in sample 2) (p<0.05). 
The total number of errors and length of stay that participants experienced were affected 
by group and admission category, and to a level of statistical significance in sample 1 
(p<0.001). In both the pre-intervention and intervention groups of sample 1 a significant 
relationship was found between length of stay and the total number of errors, as the total 
number of errors increased so did length of stay (p<0.01).
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Overall, SE scores of participants in the intervention groups were higher than those in the 
pre-intervention group (p>0.05). The SE scores of participants who received the MMI, 
during admission and at three month follow-up were more stable than those of participants 
in the pre-intervention group. In the pre-intervention group hospital stay had a negative 
effect on SE. At each data collection point SE was affected by a number of demographic 
factors (including age, type of diabetes and admission category), these relationships 
however were variable and inconsistent.
With respect to the extent to which the information needs of patients were met during 
admission and three month follow-up, there was no significant difference between the pre­
intervention and intervention groups in the number of people whose information needs had 
been met (p>0.05). In both groups, participants were interested in similar types of 
information about the medicines, most interested in ‘detailed questions about the 
medicines (98%), and least interested in ‘alternatives to medicines’ (75%).
A discussion of these findings is presented in the following chapter.
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Chapter 7: Discussion 
7.1 Overview
This chapter commences with a discussion of the findings in relation to the literature. A 
critical review of the methodology, study strengths and limitations follow. A critical 
evaluation of the research process is presented. The contribution of the study to the body 
of knowledge, methodology and theory are discussed. A number of recommendations are 
made, and a conclusion of the main points is then provided.
7.2 Part 1: Discussion of the findings in relation to the literature
It is evident from the study findings that across the intervention group of sample 1 and 
sample 2, insulin and OHA medication errors were reduced by more than 50%, and length 
of stay reduced by a median of two days. The self-efficacy scores of participants in the 
intervention group of sample 2 also increased. The results provide empirical evidence that 
the prescribing role can be successfully used by a DSN to reduce medication errors, 
reduce length of hospital stay and improve self-efficacy.
A discussion of the key issues identified from these results is presented using the following 
sub-headings ‘new ways of working’, ‘improving the quality of care’ and ‘resource 
implications’.
New ways o f working
Central to the success of this study was the opportunity created by the prescribing role for 
the DSN to work differently to overcome shortfalls in the diabetes in-patient service. Using 
new knowledge gained through prescribing, with the ability to work independently, the 
DSN was able to make more effective use of existing specialist skills and knowledge to 
support this new model of care. While a review of the literature (Carey & Courtenay 2007)
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reports that care provided by hospital DSNs includes patient and staff education, support, 
advice and medicines management, Peters et al. (2001) suggests a lack of autonomy can 
restrict practice. Undeniably, the ability to practice autonomously is a defining 
characteristic of advanced nursing practice (Bonsall & Cheater 2008), and allows nurses 
to take on skills previously associated with medical practitioners, such as prescribing 
medications. The findings therefore suggest that having the capacity to prescribe 
medicines enhanced the role of the DSN. This is in-line with the anticipated benefits of 
nurse prescribing (DH 2006), primarily introduced in the U.K as a means to improve 
patient care and access to healthcare professionals, to make better use of the skills of 
healthcare professionals and to encourage more flexible working (Ball 2009, Buchan & 
Caiman 2004, Miles et al. 2006).
In addition to supporting the anticipated benefits of nurse prescribing, expanding nurse’s 
roles and developing new areas of practice is also a central theme of the NHS 
modernization agenda (DH 1999b, 2000). In this study, the increased autonomy
associated with having the capacity to prescribe was used to develop nurse-led 
medication review, a new and extended area of practice for DSNs. While it is evident that 
nurses have been involved in assessing patients and advising doctors about patient’s 
medicines in diabetes for some time (James et al. 2009), they were unable to implement 
their recommendations legally. Through practising autonomously, the DSN prescriber in 
this study was able to take responsibility for decisions and suggestions that were made 
during the process of medication review. As a result the potential for misunderstanding 
was reduced, and patients experienced less insulin and OHA medication errors, a reduced 
length of stay and increased self-efficacy. This concurs with recent qualitative reports 
(Carey et al. 2009a, Stenner & Courtenay 2008) which suggest that as a result of taking a 
more active role in medicines management, nurse prescribers are able to avert and or 
correct prescribing errors. However, this is the first study to formally describe and evaluate 
this area of practice on patient outcomes.
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It appears therefore that DSNs who are qualified nurse independent and supplementary 
prescribes are ideally placed to use their increased autonomy to develop new models of 
care and to take a more active role in medication review. This is important given that 
developing new ways of working are vital to overcoming the constraints on doctors’ 
availability caused by the restricted work hours of junior doctors, and the reduced number 
of hours worked by increasing numbers of female doctors (Royal College of Physicians
2005), and the need to improve diabetes in-patient services.
Improving the quality o f care
Improving the quality of care in-patients receive by reducing the number of medication 
errors in prescribed drugs (DH 2004, NPSA 2007) and, providing adequate information, 
equitable, timely access to knowledgeable healthcare professionals, and continuity of care 
(DH 2003a, 2007) have become increasingly essential requirements of diabetes services. 
Despite this, a recent survey of people with diabetes indicates that only a quarter of in­
patients with diabetes are reviewed by a specialist team during their stay (HCC 2007b). 
Adopting the MMI however, ensured a consistent approach to the care in-patients 
received. The DSN prescriber was able to increase patient contact, work with patients on 
an individual basis, review their medication regime and information needs, and encourage 
patients to self-care. Consequently, the care provided from an experienced diabetes 
specialist was less fragmented, more equitable and continuous. The findings from this 
study therefore suggest that implementing these changes had a positive effect on the 
quality of care patients received, and as a result medication errors were reduced. They 
also provide some evidence that nurse prescribing can produce benefits in line with 
current government policy on improving patient safety (DH 2004, NPSA 2007) and 
improving the quality of diabetes in-patient care (DH 2003a, 2007). Additionally, they 
highlight the central role of the DSN prescriber in supporting this policy and contribute to 
the emergent body of evidence exploring the feasibility and effectiveness of service
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models for this group of patients (DH 2007, 2008b). Furthermore, they concur with 
previous qualitative reports which describe how continuity of care and safety are both 
improved when nurses adopt the prescribing role (Carey et al. 2009a, Courtenay et al. 
2009a). It would seem logical that other DSNs who are prescribers and care for this group 
of patients consider adopting the MMI. Further evaluation of the MMI using DSN 
prescribers in other U.K hospital settings is therefore required.
Despite the more consistent approach to care provided by the MMI, and attention that the 
DSN prescriber gave to the information needs of patients, findings exploring the extent to 
which these needs were met over time were inconclusive. Whilst this is the first study to 
explore the information needs of hospital in-patients, this result is in contrast to the 
emergent evidence which suggests that the majority of patients are satisfied with the 
medicines information they receive from the nurse (Courtenay et al. 2009a, Courtenay et 
al. 2009b, Latter et al. 2005, Stenner et al. 2010). Stenner et al. (2010) for example, 
recently reported that patients with diabetes in the primary care setting were happy with 
the amount information the nurse prescriber provided about their condition and the need 
for treatment.
It is evident however, that the information needs of patients with diabetes can be affected 
by both individual and organisational factors (DH 2003a, 2008b, HCC 2006). Being 
hospitalised has a significant impact on this group of patients. Many patients report that 
they lose control over their own-self management and experience unstable glycemic 
control as a result of the problems they encounter e.g. timing and quality of meals, access 
to insulin and inadequate blood glucose monitoring (DH 2003a, 2008b). Consequently, 
when patients with diabetes are admitted to hospital they do need more information (HCC
2006). Despite this, patients with diabetes have repeatedly reported a lack of information 
from health professionals during admission (Audit Commission 2000, HCC 2007a). Whilst 
it is possible therefore that a lack of control over self-management during admission,
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caused by illness or hospital medication policy, may well have affected the information 
needs of patients in the current study, the results also suggest that nurses need to pay 
greater attention to the information needs of this group of patients. Regular monitoring and 
review of information needs, using a well-validated instrument such as the medicines 
information tool used in this study, is one approach that could be adopted to improve this 
aspect of care.
Recent healthcare policy (Audit Commission 2000, DH 2003a) highlights how adequate 
provision of information supports patients’ ability to self-manage their diabetes. 
Interestingly, participants in both the pre-intervention and intervention groups rated similar 
categories of medicines information as important. They were most interested in 
information regarding the probability that the medicine would work, how to take the 
medicine, and risks of not taking the medicine. This is in contrast to previously reported 
studies (Berry et al. 2006, Berry et al. 2008, Latter et al. 2005). For example, the 74 
members of the general population surveyed by Berry et al. (2006), 54 rheumatology 
patients surveyed by Berry et al. (2008), and 115 patients surveyed by Latter et al. (2005) 
indicated that side-effects and what the medication does / how it works, were the most 
important information required by patients about their medicine.
The findings from the present study provide an initial insight into what types of medicines 
information are important to patients with diabetes. The majority of participants had been 
diagnosed with diabetes for a number of years. It therefore seems likely that they would 
have already received information on side-effects and interactions. Patients with diabetes 
have previously described how the type of information they need changes during their life 
(Hiscock et al. 2001, Stenner et al. 2010). For example, a key finding, to emerge from 
focus groups and in-depth interviews of sixty one people with diabetes, reported by 
Hiscock et al. (2001), was the need for information to be provided in an ongoing and 
incremental way as the course of the disease evolved, and life circumstances change.
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More recently, Stenner et al. (2010) similarly found that patients desire for information 
varied over time, and was greater during transition periods to a new treatment. It seems 
likely that the findings from the present study simply reflect that the types of information 
patients are interested in does change during the course of a disease. Given the 
complexity of meeting the information needs of patients with diabetes highlighted above, 
this improved understanding is important if this area of practice is to be improved. In order 
that patients receive the right amount and type of information, nurses clearly need to be 
aware of this variation. For this to be achieved, it is important that diabetes education and 
training for nurses is reviewed to ensure the content is fit for purpose.
Recent guidance recommends that optimum care for patients with diabetes is best 
achieved through a combination of drugs and non-pharmacological support (DH 2007, 
2008b, HCC 2007b). Encouraging patients with diabetes to self-manage their condition is 
a key component of this approach (DH 2001, 2003b). The improved self-efficacy scores of 
patients in the intervention group suggest that the MMI did have a positive effect on 
patients’ confidence in their ability to perform diabetes related self-care behaviours. Given 
the important predictive nature of the relationship between self-efficacy and diabetes self- 
care (Bandura 1977, Marks et al. 2005a), the findings indicate that adopting the MMI could 
help patients increase control over their diabetes and, by avoiding concerns they have 
during admission such as a lack of information and unstable glycemic control, improve the 
quality of care they receive.
Although the findings suggest that the MMI provides a new and innovative strategy to 
enhance diabetes self-efficacy, investigation of the relationship between self-efficacy and 
demographic variables identified that self-efficacy was affected by a number of factors 
(including age, type of diabetes, admission category). At each data collection point these 
relationships were found to be variable and inconsistent. The inconsistent nature of the 
relationship between diabetes self-efficacy and a range of demographic variables (e.g.
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employment status, ethnicity and marital status) has also previously been reported 
(Ludlow & Gein 1995, Sarkar et al. 2006, Sousa et al. 2005, Wang & Shiu 2004, Williams 
& Bond 2002, Wu et al. 2007). Across these six studies data were collected from a total of 
694 patients with diabetes in a variety of healthcare settings (including hospital outpatients 
and the community). In-line with the current study findings, the relationship between 
demographic variables and diabetes self-efficacy was variable and inconclusive. Although 
care must be taken in interpretation of tendencies when running multiple correlations as 
some associations will occur from chance (Field 2005), it is evident from the literature 
exploring the theory and use of self-efficacy in healthcare interventions that self-efficacy is 
a temporary and easy to influence characteristic (Bandura 1977, Clark & Dodge 1999, 
Holloway & Watson 2002). Therefore, it is likely that despite the MMI, the inconsistent 
relationships between the demographic variables and self-efficacy reported in this thesis 
reflect normal behaviour of the self-efficacy construct.
Interestingly, in both the pre-intervention and intervention groups the highest levels of self- 
efficacy were reported by patients at three month follow-up. Although there is currently no 
evidence available with which to compare this result, it is feasible that this finding 
represents a typical pattern of behaviour for diabetes self-efficacy, whereby self-efficacy 
increases after a patient is discharged from hospital. On the other hand it could be 
contended that this result represents the testing effect, whereby the improved self-efficacy 
scores at three months follow-up merely reflect the act of participation rather than any real 
change in behaviour (Becker et al. 2003). In order to understand this area in more detail 
further evaluation of the Diabetes Management self-efficacy scale using longitudinal 
intervention studies is required.
Resource implications
In addition to improving the quality of care, ensuring standards of care and the best use of 
resources are also essential requirements of modern service delivery (DH 2008c). This
127
Chapter 7: Discussion
study is the first to demonstrate that when a DSN prescriber works autonomously they are 
able provide a more efficient way of working and overcome previous inadequacies in the 
traditional healthcare system. These inadequacies include a lack of prescriptive authority. 
This meant that in order to initiate, and or titrate insulin and oral hypoglycaemic medicines 
DSNs had to work within the specific limits of a pre-arranged protocol. Additionally, care 
could only be delivered after each patient had been discussed with the medical team. This 
approach was problematic however, as many senior doctors are not available for clinical 
duties every day (Royal College of Physicians 2005), and hence were unable to ratify 
decisions that had been made. Consequently, patients experienced frequent delays in 
their diabetes treatments and inappropriate timings of their medications (Audit 
Commission 2000, DH 2003a, 2008b, James 2003). Giving nurses the capacity to
prescribe overcomes such difficulties. As previously discussed, prescribing allows nurses 
to work independently and means that they are less dependent on the availability of 
doctors. Consequently, they are able to work more efficiently, the speed with which 
patients receive their medicines is increased and care provided is more responsive to 
need.
Significantly, the findings demonstrate that compared to traditional doctor-led models of 
care, a nurse prescriber can generate similar outcomes with respect to reducing 
medication errors (loannidis & Lau 2001), reducing length of hospital stay (Cavan et al. 
2001, Sampson et al. 2006) and increasing self-efficacy (Corbett 2003). This is important 
for two reasons: firstly, the evidence generated in this study crucially demonstrates that 
nurse prescribers can provide a high standard of care. This is in contrast to concerns that 
doctors and other healthcare professionals have reported about nurse prescribers’ level of 
clinical experience (Carey et al. 2009b, Rana et al. 2009 ) and the level of pharmacology 
training nurses receive (Bradley et al. 2006). As the first study to report on this aspect of 
nurse prescribing practice, these findings may therefore help to alleviate the concerns of 
these healthcare professionals. Secondly, as the salary of a diabetes specialist nurse
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prescriber (typical pay range £30-40,000 per annum) (NHS Careers 2010a) is 
considerably less than that of a hospital consultant (range £75-100,000 per annum) (NHS 
Careers 2010b) this model of care has the potential to reduce the direct costs of care.
There are also significant cost implications associated with the reduced length of stay 
experienced by patients in this study. The reduced length of stay of patients in the 
intervention group suggests that improving the process by which patients receive their 
medicines, and reducing the number of errors they experience has a positive effect on the 
speed with which they recover. A relatively strong correlation was found to exist in this 
study between length of stay and the total number of errors. As the total number of errors 
increased in participants in sample 1, so did length of stay (p<0.01). While it is possible 
that the number of errors simply increased if patients were in hospital longer, it is 
recognised that a range of factors can affect length of stay (i.e. nature and severity of 
illness, availability of investigations, and response to treatment). Furthermore, the 
detrimental effect of medication errors on increasing length of stay has been clearly 
demonstrated in several studies (Leape et al. 1991, Vincent et al. 2001, Wilson et al. 
1995).
Based on the current study findings i.e. a median reduction in length of stay of two days 
per patient and a cost per day of £250 (DH 2010), over one year the reduction in length of 
stay is a potential cost saving of over £500,000. The potential cost savings demonstrated 
by the reduced length of stay in this study highlight how, in-line with national guidance (DH 
2008b), a DSN prescriber delivering this intervention provides good value for money. At a 
time when doctors are increasingly unable to meet patient demand (Rosen & Dewar 2004, 
Royal College of Physicians 2005), and there are ongoing financial restraints within the 
NHS that continue to affect the availability of diabetes specialist in-patients teams (DH 
2008b), this study has important implications in terms of maximising resource use, and 
providing this group of patients with a more flexible and accessible model of care.
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Considering that over 4% of total healthcare expenditure in the U.K is spent on diabetes 
(NCCCC 20008), 10% of hospital beds are occupied by patients with diabetes (DH 
2008b), and admissions for patients with diabetes are on average 2.6 days longer than 
other patients (DH 2008b), this is a significant finding which may be of particular interest to 
those involved with service improvement and quality assurance.
It is important to note however, that in line with previous research on reducing medication 
errors (Anderson & Webster 2001, loannidis & Lau 2001, Reason 2000), it is likely that 
the current study effects will only be maintained, and errors controlled if ongoing support 
and funding is provided. Consequently, healthcare organisations intending to adopt a 
similar model of care would need to ensure ongoing support and funding is provided to 
those involved.
Given the implications of supporting this model of care in terms of manpower and 
resources it is important that the effects of the intervention are considered more closely. In 
both samples, monitoring and administration errors were substantially reduced whereas 
the effect on prescribing errors was less notable. There may well be a case therefore to 
strengthen the elements of the MMI directed towards the prescribing stage of the 
medication process. Additionally, it may also prove beneficial if the DSN received 
additional support from either a pharmacist or Diabetiologist in this area of practice.
The extent to which errors were reduced by the intervention was also affected by 
admission category. In sample 1 for instance, on four of the study wards (i.e. medicine, 
kidney disease, vascular surgery and vascular amputation) the average number of errors 
was reduced by nearly two thirds, whereas on the orthopaedic and surgical wards the 
number of errors increased. Patients on the orthopaedic and surgical wards tended to be 
admitted for planned and routine procedures, had a shorter length of stay and were less
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likely to be treated with insulin, whereas the greatest intervention effects were found on 
wards such as medicine, kidney disease, vascular surgery and vascular amputation where 
patients tended to have unplanned and longer admissions. Consequently, there may well 
be a case for targeting the MMI to specific groups of patients such as those who have 
unplanned and longer admissions. In order to understand this area more fully, further 
evaluative research on patients who have unplanned and longer admissions is required.
Admission category also influenced the total number of errors and length of stay patients 
experienced. Compared to the other study wards (i.e. medicine, kidney disease, 
orthopaedics and surgery), patients admitted across the two vascular wards experienced 
the longest length of stay and greatest number of errors. Although caution should be used 
when interpreting this finding as only 10% of study patients were admitted to these two 
wards, it is useful to consider why this group of patients experienced the longest length of 
stay and greatest number of errors. Patients admitted to the vascular wards were 
generally older than those in the other admission categories (i.e. medicine, kidney 
disease, surgery, and orthopaedics) and possibly had a number of other co-morbidities 
requiring complex medicines regimes increasing the likelihood of errors occurring.
There is substantial evidence to suggest that the potential for error increases when 
patients have co-morbidities and medicine regimes that involve poly-pharmacy (DH 2004, 
NPSA 2007, Wilson et al. 1995). Evidence of a relationship between co-morbidities and 
medication errors has also previously been reported (Manley et al. 2003). In a review of 
the medical records of 133 patients undergoing ambulatory haemodialysis, Manley et al. 
(2003) reported the number of co-morbidities correlated positively with the number of 
medication error problems. The current study findings suggest that healthcare staff need 
to be more vigilant during the process by which this group of patients i.e. those admitted to 
the vascular surgery and vascular amputation wards receive their medicines. Additionally, 
it could be argued that even though the MMI provided one to two educational sessions to
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doctors and nurses, this may not be sufficient to meet the learning needs of healthcare 
staff that care for patients with more complex medication regimes. Healthcare staff 
working on vascular surgery or vascular amputation wards, where patients tend to have 
more complex healthcare needs, may therefore require extra educational sessions. A 
more formal assessment of diabetes knowledge before the intervention would help ensure 
that the content of the MMI is appropriate to the learning needs of healthcare staff working 
in different clinical areas.
7.3 Part 2: Discussion of Methodology
Overall, the study was successful in that each research question was answered. The 
experimental approach and methods of data collection generated objective data on the 
outcome measures of interest i.e. medication errors, length of stay, self-efficacy, the extent 
to which patients information needs are met, and the types of information patients consider 
to be important about their medicines. Hypotheses 1-3, as described in Chapter 1.4, were 
supported by the results. However, the evidence from this study does not support 
hypothesis 4, as hospital in-patients with diabetes, who received the MMI from a DSN 
prescriber, did not report an improvement in the extent to which their medicines 
information needs were met.
The inclusion criteria for sample 2 were based on data provided by the admissions 
department of the hospital regarding average length of stay, and the need to ensure 
patients were in hospital long enough to receive the MMI. During data collection difficulties 
were experienced identifying patients with a predicted length of stay of three days, and 
recruiting participants for sample 2. At the end of the pre-intervention phase only twenty 
people had been recruited to this sample. Therefore in order to increase numbers the pre­
intervention phase was extended by an additional month.
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During the development of the MMI it was estimated that patients, doctors and nurses 
would require one to two educational sessions. However, the DSN reported that 
sometimes their needs were greater. Although the DSN was able to devote twenty four 
hours a week to the MMI, it was reported that at times it was difficult to deliver the 
intervention to all participants in this time period.
In order to maintain the consistency and quality of the intervention, it may be useful if the 
educational sessions, for patients, doctors and nurses, were more structured. A 
summative assessment of participants’ knowledge before and after the intervention, 
including an assessment of the patient’s ability to self-manage their diabetes, would also 
support a more detailed evaluation of this aspect of the intervention. The amount and type 
of education and information received by patients and healthcare staff would be accurately 
recorded, and this in turn could be used to calculate the necessary level of manpower and 
resources.
7.3.1 Study Strengths
The study gives a clear and detailed description of the rationale and content of each stage 
of the intervention. Each stage of the MMI was based on evidence from the literature. The 
quality of this process is a strength of the study as it would be relatively easy for another 
researcher to use the MMI in a future study.
This study used one nurse to deliver the intervention. One of the drawbacks of this 
approach is the possibility of character bias which reduces the generalizability of the 
findings. In contrast, a key strength of this approach is that it helped the implementation, 
quality and standardisation of the intervention.
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A high number of participants completed each of the three questionnaires. Seventy three 
percent out of a sample of 56 patients originally recruited to sample 2 completed all three 
questionnaires. It is not possible to compare these completion rates as this is first study in 
this subject area to collect three sets of data from the same group of patients. A 
completion rate of over 70% is classed as reasonable (Polit et al. 2001). The low attrition 
rate therefore strengthens study findings and reduces the risk of bias.
A further strength of the study is the reliability of the instrument that was used to measure 
diabetes self-efficacy. At each data collection point, the internal consistency of the 
modified Diabetes Management self-efficacy scale was found to be high (alpha 
coefficients 0.79-0.92). This indicates that the self-efficacy scale reliably assessed efficacy 
expectations of sample 2 towards diabetes self-care activities.
The comparable effects of the intervention on outcome measures across sample 1 and 2 
suggest that the study has good generalizability. The large size of sample 1 meant that 
these effects were at a level of statistical significance. This enhances the generalizability 
of the findings, and confidence that the results could be reproduced if the study was 
repeated.
7.3.2 Study Limitations
Although it has been shown that the research questions were successfully answered, 
there were limitations to the methods adopted. This study used a convenience sample of 
patients whereby all patients admitted to one of the six wards during the three month pre­
intervention and three month intervention period were included in the study i.e. it was not a 
random sample. There is the possibility therefore that the sample is not representative of 
patients with diabetes, and hence a degree of caution should be used when interpreting 
the findings.
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For example, the study recruited few ethnic minority patients to sample 2. As there are 
specific ethnic groups, such as South Asian and African Caribbean, who have a higher 
prevalence of type 2 diabetes (BMA 2004), the generalizability of the findings from this 
sample are somewhat reduced. An enhanced sampling frame would ensure that a greater 
proportion of patients with a black or minority ethnic background were recruited in future 
studies.
Additionally, the pre-intervention and intervention groups of both samples 1 and 2 were 
similar with regard to demographic information, apart from admission category. In both 
samples a greater proportion of patients were admitted to the medical ward during the 
intervention. This difference, which may have been influenced by seasonal variation, could 
have affected study outcome measures, which does reduce generalizability of the findings.
The reliability of the insulin and OHA error data is also a possible weakness of this study. 
The insulin and OHA medication error extraction charts from the first 20 participants were 
reviewed and analysed by two people. Reliability would have been increased further, if a 
10-20% random sample of all the medication charts were reviewed and analysed by two 
people. Additionally, the medication charts (i.e. insulin chart, sliding scale chart and / or old 
medication chart) for sixteen patients were unavailable during data extraction making it 
difficult to identify errors. This may have affected the overall findings.
Participants in sample 2 were generally old and infirm and a number had also experienced 
some degree of amputation to their leg(s). Consequently, they found some questions*on 
the self-efficacy scale difficult to answer, specifically those related to foot examination and 
going to parties (Qs 6, 11, 12). It is not known what, if any, effect this had on their 
responses or the self-efficacy results.
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The small size of sample 2 reduces the generalizability of the findings related to self- 
efficacy and patient’s medicines information needs as it cannot be said to be truly 
representative of hospital in-patients with diabetes. Less confidence can therefore be put 
in the strength of the findings related to self-efficacy and patients’ medicines information 
needs. It would be useful if a more representative sample of patients with diabetes were 
used in future studies exploring diabetes self-efficacy and patients’ medicines information 
needs.
7.3.3 Critical evaluation of the research process
As a researcher it is important to review and critically evaluate the research process and to 
reflect on this process. Overall the study was successful in answering the research 
questions. The experimental approach that was adopted generated objective data on the 
outcome measures of interest.
Although concerns have been expressed by the nursing discipline over the fundamental 
issue regarding the suitability of scientific enquiry for investigating nursing interventions 
(Poole & Jones 1996), the researcher has demonstrated that the chosen methodology and 
methods were the appropriate choice to answer the research questions.
The study gives a clear and detailed account of each stage of the research process, from 
designing the intervention, developing the tools for data collection, ethical approval and 
data collection. At each stage the researcher kept detailed records of what helped or 
hindered the process.
For example, some minor difficulties were experienced by the researcher during the period 
of data collection. The hospital is located 150 miles from the University of Reading (the 
university where the researcher was registered as a student during data collection). 
Therefore it was not practical for the researcher to be on site all the time during data
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collection. The DSN prescriber and Service Improvement Manager from the study hospital 
provided additional support recruiting patients.
Participants in sample 2 were generally old and infirm. It would be useful if a more 
representative sample of patients with diabetes were used in future studies. This would 
support the use of other research methods such as interviews, which would allow a more 
detailed exploration of the factors which appear to affect self-efficacy.
In questionnaires 2 and 3, participants were asked to indicate the extent to which their 
information needs were met. However, on reflection it is evident that several factors could 
have affected the information needs of this group of patients including time since 
diagnosis, presence of complications and co-morbidities etc. In future this question should 
be refined to make it more specific to patient information needs during the study period.
On reflection, it would have been useful if more clinical data had been collected e.g. blood 
glucose level, HbA1C and symptoms of hypo and hyperglycaemia. These well established 
physiological measures would have provided additional data and further evidence to 
support the findings. It may be useful to consider their inclusion in future studies that adopt 
the MMI.
During this project the researcher has achieved a steep learning curve. Undertaking 
research in a new practice setting, and working in an unfamiliar geographical area were 
both challenging aspects of this process. However, this study has allowed the researcher 
to appreciate the complexities of the research process, and experience the challenges of 
working in collaboration with members of an unfamiliar hospital trust. This vital experiential 
learning has since been applied to other research projects that the researcher has been 
involved with.
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7.4 Part 3: Contribution to knowledge, methodology and theory
This section provides the contribution this study has made to knowledge, understanding, 
methodology and theory, each of which is explored below.
a) The contribution to knowledge and understanding
A quasi-experimental approach was adopted in order to evaluate the effect of the MMI 
from a DSN prescriber and generate objective data on measures related to diabetes in­
patient outcomes and quality of care. The MMI, a new intervention which combined key 
elements from the established role of the DSN (i.e. medicines management, education, 
support and promotion of self-care) with the relatively new role as a prescriber, was 
successfully developed and implemented.
In this study, the prescribing role was specifically used to develop an intervention that 
addressed recognised shortfalls in the diabetes in-patient service. The study is the first to 
demonstrate that through practising autonomously a nurse prescriber was able to 
overcome previous inadequacies in the traditional healthcare system. These inadequacies 
include the need to discuss each patient with the medical team in order to deliver 
medicines to patients, and having limited access to a specialist prescriber. This concurs 
with several recent reviews of the literature (Ball 2009, Cooper et al. 2008, Drennan et al. 
2009) that have described how the prescribing role increases autonomy, supports 
advanced nursing practice and allows nurse to develop new ways of working. This study 
adds an important new dimension to this body of evidence which, in addition to a dearth of 
literature on nurse prescribers who provide in-patient services, contains a lack evidence 
related to quality of care and patient outcome measures.
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Several significant results across the intervention group of sample 1 and sample 2, such 
as the reduced number of in insulin and OHA medication errors, and reduced length of 
stay were identified. Additionally, in sample 2 the self-efficacy scores of participants were 
increased. These findings contribute to our knowledge and understanding about the 
benefits of the prescribing role. They are also the first study effects to be reported on 
patient outcome measures. This objective data confirms previous qualitative study reports 
that nurse prescribing can improve quality of care (Carey et al. 2009a, Latter et al. 2005) 
and improve patient safety (Bradley et al. 2007, Courtenay et al. 2009a, Stenner & 
Courtenay 2008).
Crucially, the findings demonstrate that care provided by a nurse prescriber is of a 
comparable high standard to traditional models of care, and this is important for two 
reasons. Firstly, as the NHS attempts to control costs, ensuring the quality and 
effectiveness of care is an increasingly essential requirement of service delivery (DH 
2008c). Secondly, doctors and other health professionals have reported mixed views 
about nurse prescribers’ level of clinical experience (Carey et al. 2009b, Rana et al. 2009 ) 
and the level of pharmacology training nurses receive (Bradley et al. 2006). No previous 
studies have reported on this aspect of nurse prescribing practice. The evidence 
generated in the current study demonstrates an important strength of the care nurse 
prescribers provide, which may also help alleviate the concerns expressed by other 
healthcare professionals.
This study demonstrated that significant cost savings could be made by a DSN prescriber 
delivering this intervention to the diabetes in-patient service. This adds to our knowledge 
and understanding about the financial implications associated with the prescribing role, 
and adds an important new facet to previously reported benefits. It is also an important
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contribution to the body of knowledge for those who are involved with service improvement 
and quality assurance.
The introduction of nurse-led medication review was an important aspect of the care 
provided by the DSN prescriber. Although there are some recent qualitative reports (Carey 
et al. 2009a, Stenner & Courtenay 2008) that nurse prescribers are taking a more active 
role in medicines management, this is first study to formally evaluate this aspect of care on 
patient outcomes. The successful implementation of this new area of practice adds to our 
knowledge and understanding of how the prescribing role can be used to expand nurses’ 
roles and improve medication safety.
This is the first time the information needs of hospital in-patients have been explored. The 
results highlight the complexity of meeting the information needs of patients with diabetes. 
They also suggest that nurses need to pay greater attention to establishing the information 
needs of this group of patients.
The study additionally explored the different categories of medicines information that are 
important to in-patients with diabetes. The findings indicate that in-patients with diabetes 
are interested in different categories of information to those previously reported in the 
literature (Berry et al. 2006, Berry et al. 2008, Latter et al. 2005).They also indicate that the 
categories of information patients are interested in does change during the course of a 
disease. This improved understanding about information needs is important as patients 
with diabetes have repeatedly reported a lack of information during admission.
In both samples, the MMI had a more dramatic effect on reducing monitoring and 
administration errors. These findings are important as they suggest the MMI may need 
strengthening with respect to the prescribing stage of the medication process. They also
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contribute to our knowledge and understanding about the potential strengths and 
weaknesses of this model of care.
Other significant results that this study found were, in sample 1 a strong relationship 
between the total number of errors and length of stay i.e. as the total number of errors 
increased so did length of stay. The extent to which insulin and OHA errors were reduced 
was affected by admission category, with the most notable effects found in patients who 
tended to have unplanned and longer admissions. Admission category also affected the 
total number of errors and length of stay, with patients admitted to the two vascular wards 
experiencing the greatest number of errors and longest length of stay. These findings 
contribute to our knowledge and understanding, as they have not been reported in other 
studies exploring this area of practice.
Dissemination of the study findings has been achieved in several ways. At a local level this 
was achieved by presenting the results to ward staff and senior hospital managers across 
the hospital trust where the study was conducted. Further dissemination of the study 
findings within the field of nursing and healthcare practice has been achieved through 
national and international conferences presentations of the literature review and study 
findings relating to medication errors, length of stay and self-efficacy. A selection of these 
conference presentations are presented below:
Carey, N, Courtenay, M (2006): An Evaluation of the DSN on service delivery in
secondary care Interim Findings: International Nursing Research Conference:
RCN, York, UK: (21-24 March)
Carey, N, Courtenay, M (2006): An Evaluation of the DSN on service delivery in secondary 
care Interim Findings: International Society for Quality in Health, London, UK: (22- 
25th October)
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Carey, N, Courtenay, M (2007): A Review of the Activity and Effects o f Nurse-led Care in 
Diabetes; Evidence-Based Nursing Practice, Hong Kong, China: (19-21st April) 
Carey, N, Courtenay, M. James, J. Hills, M, Roland. J (2007) An Evaluation o f a Specialist 
Nurse Prescriber on Diabetes In -Patient Service Delivery Federation of European 
Nurses in Diabetes, 12th Annual Conference, Amsterdam, Netherlands: (14-15th 
September)
Carey, N, Courtenay, M (2007): A Review o f the Activity and Effects o f Nurse-led Care in 
Diabetes; Federation of European Nurses in Diabetes, 12th Annual Conference, 
Amsterdam, Netherlands: (14-15th September)
Several articles have been published in peer reviewed journals (Carey & Courtenay 2007, 
Carey et al. 2008, Courtenay et al. 2007), and this has supported wider dissemination of 
the study findings within the field of nursing and healthcare practice. A copy of each article 
can be found in Appendix 12.
b) Contribution to research methodology
A lack of studies adopting an experimental approach or longitudinal design, as discussed 
in chapter 2.5, was highlighted in the literature reporting the effects of nurse-led 
interventions and patient outcomes on in-patients with diabetes.
The study offers an original contribution to methodology in this area as it is the first to use 
an experimental approach to explore the effects of an intervention provided by a DSN 
prescriber on in-patients with diabetes. The study, a quasi-experimental design, is 
associated with a high level of rigour and internal validity (Polit et al. 2001). This means a 
relatively high level of confidence can be inferred from the analysis of the data that the 
MMI was causally linked to the study outcomes.
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The longitudinal design is also original, and the study is both first to collect a series of data 
from in-patients with diabetes and report on outcome measures related to quality of care 
such as self-efficacy and patient information needs.
c) Contribution to theory
A need for studies to adopt a less medically orientated approach and more theoretical 
approach to this area of research was highlighted in the literature review chapter. The 
theory of medication errors (Leape 1994, Reason 1990), a general systems theory, was 
used as a framework to develop the medicines management intervention. This is the first 
study to use a theoretical framework in this area of research. The theoretical framework 
was used to guide the research process and ensured that the intervention adopted a 
structured and systematic approach to addressing some of the concerns in the diabetes 
in-patient service.
The error findings from both samples also provide further support for the theory of 
medication errors. As Reason (1990), Leape (1994) and the NPSA (2007) report, 
whatever system or approach to patient safety is adopted human error is inevitable and it 
is unlikely that while errors can be reduced they will ever be totally eliminated. A similar 
pattern of behaviour was evident in the findings of this study. Although errors were 
reduced by more than 50% across the intervention group of both samples 1 and 2, a high 
number of errors remained following the three month intervention period.
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7.5: Part 4: Recommendations
The findings from this study provided an insight in to how the prescribing role can be used 
by a DSN to improve diabetes in-patient services. The results have confirmed and 
extended the body o f knowledge in this area. In light of the findings, and the strengths and 
limitations of the study a number of recommendations have been made and are presented 
below.
7.5.1 Recommendations for future research
This study evaiuated the effect of a MMI provided by a DSN prescriber on in-patient 
services in one district general hospital in the U.K. It is therefore important that further 
evaluation of the MMI is conducted using DSN prescribers in other hospital settings across 
the U.K.
Although beyond the scope of the current study, in future studies it would also be useful to 
evaluate the effect of the MMI on clinical measures used to monitor diabetes control e.g. 
blood glucose levels, and HbA1C. This additional data would provide further evidence to 
support the results found in this study.
A randomised controlled study could be conducted to explore the MMI further. This would 
ensure that the sample was more representative of patients with diabetes and reduce the 
risk of bias and erroneous findings. This would also increase the generalizability of the 
findings.
It is possible that nurse prescribers caring for other groups of patients who, similarly to 
patients with diabetes, are vulnerable to medication errors e.g. children and adults aged 
over 70 (NPSA 2007), may also be able to make a contribution to reducing medication 
errors. It would therefore be useful to explore the use of the MMI using nurses working in 
different clinical settings.
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Given the complexity of meeting the information needs of patients with diabetes, further 
evaluation of the medicines information tool, using patients with varying disease duration 
and from a range of practice settings, including primary care is warranted. This would 
contribute to our understanding about the types of information patients are interested, and 
add to the validity of the tool.
In this study patients who tended to have unplanned and longer admissions, experienced 
the greatest reduction in insulin and OHA medication errors. In order to ensure the best 
use of resources and determine if there is a case for targeting the MMI to specific groups 
of patients, further evaluative research on patients who have unplanned and longer 
admissions is required.
The findings from this study are only applicable to the healthcare system in the U.K. In 
order to establish if the MMI is an effective model of care in other healthcare systems, it 
would be useful to conduct further studies in other countries that have a similar high 
prevalence of diabetes, and where nurses also have prescriptive authority i.e. U.S, 
Australia and Canada.
7.5.2 Recommendations
1) In order to overcome inadequacies in the traditional doctor-led model of care 
and improve the process by which in-patients with diabetes receive their 
medicines, it is recommended that other diabetes specialist nurses, who are 
involved with medicines management and working at advanced levels of 
practice, consider adopting the prescribing role.
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2) In order to Improve patient safety and the quality of diabetes in-patient 
services, it is recommended that other DSNs prescribers who care for this 
group of patients explore the adoption of the MMI.
3) In line with current government policy on improving patient safety (DH 2004, 
NPSA 2007), it is recommended that national policy makers encourage and 
support nurse prescribers who care for other patients, that are vulnerable to 
medication errors e.g. children, and adults aged over 70 (NPSA 2007), to 
explore the feasibility and effectiveness of the MMI in different practice settings.
4) The MMI provided by a DSN prescriber can produce as high quality care as 
traditional models of doctor-led care and achieve as good outcomes for 
patients. Given that the MMI has the potential to reduce the direct costs of 
care, managers and workforce planners should consider increasing the number 
of DSN prescribers who are employed to work for diabetes specialist in-patient 
teams.
5) The MMI provided by a DSN prescriber improved the process by which in­
patients with diabetes received their medicines and as a result medication 
errors and length of stay reduced and diabetes self-efficacy increased. For 
these effects to be maintained managers need to ensure ongoing support and 
funding for the MMI is secured through local commissioning arrangements for 
workforce planning and service delivery.
6) In order that patients with diabetes are able to self-manage their condition they 
need to receive the right amount and type of information about their medicines. 
For this to be achieved, nurses need to be aware of the various factors that 
affect this aspect of care. It is therefore recommended that diabetes education 
and training for nurses is reviewed to ensure it is fit for purpose.
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7.6 Conclusions
DSNs have an integral role to play in improving the services in-patients with diabetes 
receive and prescribing is an increasingly important part of the care they provide. The 
findings presented in this thesis demonstrate that the prescribing role can be successfully 
used by a DSN to develop a new model of care and overcome shortfalls in the diabetes in­
patient service.
In addition to taking responsibility for prescribing decisions the study has shown that the 
increased autonomy provided through the prescribing role allowed the DSN to take a more 
active role in medication review. This in combination with the more consistent approach to 
care the MMI provided had a positive effect on patient safety and the quality of care in­
patients with diabetes received. Crucially/the care provided was of a comparable high 
standard to traditional doctor-led models of care.
This model of care has important implications in terms of maximising resource use, the 
potential to reduce direct costs of care and, providing a more flexible and accessible 
model of service delivery. In order to understand this contribution more fully, further 
evaluation of the MMI using DSN prescribers in other UK hospital settings is required.
It is likely that nurse prescribing is having similar positive effects in other clinical areas. If 
the impact that nurse prescribing can have on healthcare provision is to be fully realised, 
further evaluative research must be conducted, using patients from different clinical 
settings.
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Appendix 1 The University of Reading
Academic Services Directorate
Whiteknights, PO Box 217 
Reading RG6 6AH
phone +44 (0)118 378 6273 
fax +44(0)118 378 6248
emaiI d.a.stannard@reading.ac.uk
Dr M. Courtenay,
School of Health and Social Care, 13 July 2005
Dear Dr Courtenay,
Ethics and Research Committee
Project 05/14: Assessing the effects of a diabetes specialist nurse (and qualified nurse 
prescriber) on self efficacy, medication errors and utilisation of health services in 
individuals with diabetes
Thank you for your recent letter. On behalf of the Ethics and Research Committee the 
Chairman has agreed that the above project be allowed to'proceed but, in so doing, takes the 
view that it should additionally be considered by the relevant local NHS Research Ethics 
Committee. He recognises in so recommending that this remains a matter for negotiation 
between yourself and the Peterborough and Stamford NHS Foundation Trust.
Yours sincerely,
D.A. Stannard 
Director of Quality Support
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Appendix 2
The University of Reading
The University of Reading 
School of Health and Social Care 
Bulmershe Court 
Reading 
RG6 1HY
Tel: 0118 3785840
Date as posted
Dear
Self-efficacy (or confidence) questionnaire for people living with diabetes
I am a researcher at Reading University. I am undertaking a study (towards a PhD), evaluating the 
role of the Diabetic Specialist Nurse. You have been asked to participate in this research because 
you have diabetes and I would like you to give me your views about living with this condition.
The study compromises of three similar questionnaires. These questionnaires will be given out at 
the beginning of your hospital stay (questionnaire 1), at the end of your stay (questionnaire 2), 
and three months following your discharge (questionnaire 3). In order to complete the third 
questionnaire, you will be contacted by letter or telephone.
The questionnaire will take about 10 minutes to complete. A stamped addressed envelope (SAE) 
is enclosed for you to return it to me. If you feel, after reading this information, that you do not 
want to take part in this study, please return the questionnaire in the envelope provided. The 
research will be complete by June 2006, and the results will be made available to you via the 
Diabetic Specialist Nurse when you next attend the hospital out patient clinic. Your participation 
in this survey is entirely voluntary, and your responses will be confidential and anonymous.
If you have any questions, or require help completing the questionnaire, please do not hesitate to 
contact me. Thank you for reading this letter and I look forward to receiving your completed 
questionnaire.
Thank you for your participation 
Yours Sincerely
Nicola Carey 
Senior Research Fellow
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The University of Reading
CONSENT FORM
Title of Project: A study to evaluate the effect of the Diabetic
Specialist Nurse Prescriber on self-efficacy for 
people with diabetes
Name of Researcher: Nicola Carey
Please initial box
I confirm that I have read and understand the information I I
sheet dated............. for the above study and have
had the opportunity to ask questions.
I understand that my participation is voluntary and that I O
am free to withdraw at any time, without giving a reason, 
without my medical care or legal rights being affected.
I agree to take part in the above study. I I
Name of Patient Date Signature
Name of Researcher Date Signature
2.
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DATA EXTRACTION CHART: 
INSULIN AND OHA MEDICATION ERRORS
Patient ID Number of errors present
Administration
Errors
Insulin doses not signed as given
Inappropriate dose of short acting 
insulin administered in response to 
hyperglycaemia
OHA medication not signed as given
Sliding scale doses not signed as 
given.
Omission of Insulin after 
hypoglycemia
Charts Incomplete
Prescribing Errors Name of insulin incorrect
Insulin chart not signed by prescriber
Unit Abbreviated to ‘u’ and unclear
Insulin not written up
Number of units of dose unclear
Prescription chart not signed by 
prescriber
Monitoring Errors Insulin/Oral medication dose not 
adjusted when persistent 
BG>14mmols
Insulin/Oral medication dose not 
adjusted with persistent BG <4mmol
REIVEWER INITIALS CHECKED BY INITIALS
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STUDY NUMBER
1. How long is it since you were diagnosed with diabetes?
Less than 1 year D
1-15 years D
Over 15 years D
2. Do you have any other illnesses or diseases?
No □
Yes □
Please specify:
3. Age: under 50 years D
51-69 years D
Over 70 years D
4. Sex: Male D
Female D
5. C urrent marital status
Married/living with partner □
Divorced/separated □
Single (never married) □
Widowed D
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6. What type of accommodation do you live in?
Detached/semi detached (including bungalow) □  
Terrace (including end terrace) □
Purpose built flat/maisonette in block D
Self contained flat in a converted house □
Rooms in a converted house i.e. 
not self contained □
Caravan/houseboat/mobile home □
Nursing home D
Other □
7. Are you currently employed?
No □
Yes □
Please specify............................................................
8. What is your ethnic group?
White □
Mixed D
Asian/Asian British □
Black/Black British □
Chinese D
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The University of Reading 
School of Health and Social Care
Self-Efficacy (or confidence) Questionnaire 
for People living with Diabetes
Study Number
Qi 173
• Thank you for agreeing to take part in this study. We are 
evaluating the role of the Diabetic Nurse Specialist
« The questionnaire will take about 10 minutes to complete
• The answers you give will be used in planning future service 
provision
• If  you feel after reading this that you do not want to take part, 
or if you feel you want to withdraw at any point please return 
the questionnaire in the envelope provided.
• Please read every question carefully before you answer it 
and try to answer each one. Don’t worry if you make a 
mistake; simply cross out the mistake and put a mark in the 
appropriate place
© When you have completed the questionnaire please return it 
in the envelope provided
• The study is anonymous and the information you give will be 
treated in the strictest confidence
Qi 174
CONFIDENCE IN ACTIVITIES TO MANAGE DIABETES
Below is a list of activities you have to perform to manage your diabetes. 
Please read each one and then put a circle through the number which best 
describes how confident you usually are that you could carry out that 
activity.
For example, if you are completely confident that you are able to check your 
blood sugar levels when necessary, put a circle through 6. If you feel that 
most of the time you could not do it, put a line through 1 or 2.
For example_____________ _____________________________________________ _____
Cannot do at all Certain can do
1 2 3 4 5 ©
I am confident th a t..........
1. I am able to check my blood sugar if necessary
Cannot do at all Certain can do
1 2 3 4 5 6
2. I am able to correct my blood sugar when the sugar level is too high
Cannot do at all Certain can do
1 2 3 4 5 6
3. I am able to correct my blood sugar when the blood sugar level is too low
Cannot do at all Certain can do
1 2 3 4 5 6
4. I am able to choose the correct foods
Cannot do at all Certain can do
1 2 3 4 5 6
Ql 175
5. I am able to keep my weight under control
Cannot do at all Certain can do
1 2 3 4 5 6
6. I am able to examine my feet for cuts
Cannot do at all Certain can do
1 2 3 4 5 6
7. I am able to adjust my eating plan when ill
Cannot do at all Certain can do
1 2 3 4 5 6
8. I am able to follow a healthy eating pattern most of the time
Cannot do at all Certain can do
1 2 3 4 5 6
9. I am able to take exercise if the doctor advises me
Cannot do at all Certain can do
1 2 3 4 5 6
10. When taking more exercise I am able to adjust my eating plan
Cannot do at all Certain can do
1 2 3 4 5 6
11.1 am able to follow a healthy eating pattern when I am away from home/ on holiday
Cannot do at all Certain can do
1 2 3 4 5 6
Q1 176
12.1 am able to follow a healthy eating pattern when I am out at a party
Cannot do at all Certain can do
1 2 3 4 5 6
13.1 am able to adjust my eating plan when I am feeling stressed or anxious
Cannot do at all Certain can do
1 2 3 4 5 6
14.1 am able to take my medication as prescribed
Cannot do at all Certain can do
1 2 3 4 5 6
15. I am able to adjust my medication when I am ill
Cannot do at all Certain can do
1 2 3 4 5 6
Thank you for taking the time to complete the questionnaire 
Please check that you have filled in each questions and return it in the
envelope provided
At the end of your stay in hospital you will be asked to fill in a repeat of this
questionnaire
This information is covered by the Data Protection Act
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The University of Reading 
School of Health and Social Care
Self-Efficacy (or confidence) Questionnaire 
for People living with Diabetes
Study number
Q2 178
• Thank you for agreeing to take part in the next part of this 
study. We are evaluating the role of the Diabetic Nurse 
Specialist
® The questionnaire will take about 10 minutes to complete
• The answers you give will be used in planning future service 
provision
® If you feel after reading this that you do not want to take part, 
or if you feel you want to withdraw at any point please return 
the questionnaire in the envelope provided.
® Please read every question carefully before you answer it 
and try to answer each one. Don’t worry if you make a 
mistake; simply cross out the mistake and put a mark in the 
appropriate place
® When you have completed the questionnaire please return it 
in the envelope provided
® The study is anonymous and the information you give will be 
treated in the strictest confidence
Q2 179
CONFIDENCE IN ACTIVITIES TO MANAGE DIABETES
Below is a list of activities you have to perform to manage your diabetes. 
Please read each one and then put a circle through the number which best 
describes how confident you usually are that you could carry out that 
activity.
For example, if you are completely confident that you are able to check your 
blood sugar levels when necessary, put a circle through 6. If you feel that 
most of the time you could not do it, put a line through 1 or 2.
For example
Cannot do at all Certain can do
1 2 3 4 5 ©
I am confident that
1. I am able to check my blood sugar if necessary
Cannot do at all Certain can do
1 2 3 4 5 6
2. I am able to correct my blood sugar when the sugar level is too high
Cannot do at all Certain can do
1 2 3 4 5 6
3. I am able to correct my blood sugar when the blood sugar level is too low
Cannot do at all Certain can do
1 2 3 4 5 6
4. I am able to choose the correct foods
Cannot do at all Certain can do
1 2 3 4 5 6
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5. I am able to keep my weight under control
Cannot do at all Certain can do
1 2 3 4 5 6
6. I am able to examine my feet for cuts
Cannot do at all Certain can do
1 2 3 4 5 6
7. I am able to adjust my eating plan when ill
Cannot do at all Certain can do
1 2 3 4 5 6
8. I am able to follow a healthy eating pattern most of the time
Cannot do at all Certain can do
1 2 3 4 5 6
9. I am able to take exercise if the doctor advises me
Cannot do at all Certain can do
1 2 3 4 5 6
10. When taking more exercise I am able to adjust my eating plan
Cannot do at all Certain can do
1 2 3 4 5 6
11.1 am able to follow a healthy eating pattern when I am away from home
Cannot do at all Certain can do
1 2 3 4 5 6
Q2 181
12.1 am able to follow a healthy eating pattern when I am out at a party
Cannot do at all Certain can do
1 2 3 4 5 6
13.1 am able to adjust my eating plan when I am feeling stressed or anxious
Cannot do at all Certain can do
1 2 3 4 5 6
14.1 am able to take my medication as prescribed
Cannot do at all Certain can do
1 2 3 4 5 6
15. I am able to adjust my medication when I am ill
Cannot do at all Certain can do
1 2 3 4 5 6
The next question is about your information needs:
16. During your admission, to what extent have your information needs been met?
1 2 3 4 5 6
Unmet Totally met
Thank you for taking the time to complete the questionnaire 
Please check that you have filled in all the sections and return it in the
envelope provided
In 3 months time you will be asked to fill in a repeat of this questionnaire 
This information is covered by the Data Protection Act
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The University of Reading 
School of Health and Social Care
Self-Efficacy (or confidence) Questionnaire 
for People living with Diabetes
Study number
• Thank you for agreeing to take part in final part of this study. 
We are evaluating the role of the Diabetic Nurse Specialist
® The questionnaire will take about 10 minutes to complete
• The answers you give will be used in planning future service 
provision
® If you feel after reading this that you do not want to take part, 
or if you feel you want to withdraw at any point please return 
the questionnaire in the envelope provided.
® Please read every question carefully before you answer it 
and try to answer each one. Don’t worry if you make a 
mistake; simply cross out the mistake and put a mark in the 
appropriate place
@ When you have completed the questionnaire please return it 
in the envelope provided
• The study is anonymous and the information you give will be 
treated in the strictest confidence
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CONFIDENCE IN ACTIVITIES TO MANAGE DIABETES
Below is a list of activities you have to perform to manage your diabetes. 
Please read each one and then put a circle through the number which best 
describes how confident you usually are that you could carry out that 
activity.
For example, if you are completely confident that you are able to check your 
blood sugar levels when necessary, put a circle through 6. If you feel that 
most of the time you could not do it, put a line through 1 or 2.
For example
Cannot do at all Certain can do
1 2 3 4 5 ©
I am confident that
1. I am able to check my blood sugar if necessary
Cannot do at all Certain can do
1 2 3 4 ~ 5 6
2. I am able to correct my blood sugar when the sugar level is too high
Cannot do at all Certain can do
1 2 3 4 5 6
3. I am able to correct my blood sugar when the blood sugar level is too low
Cannot do at all Certain can do
1 2 3 4 5 6
4. I am able to choose the correct foods
Cannot do at all Certain can do
1 2 3 4 5 6
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5. I am able to keep my weight under control
Cannot do at all Certain can do
1 2 3 4 5 6
6. I am able to examine my feet for cuts
Cannot do at all Certain can do
1 2 3 4 5 6
7. I am able to adjust my eating plan when ill
Cannot do at all Certain can do
1 2 3 4 5 6
8. I am able to follow a healthy eating pattern most of the time
Cannot do at all Certain can do
1 2 3 4 5 6
9. I am able to take exercise if the doctor advises me
Cannot do at all Certain can do
1 2 3 4 5 6
10. When taking more exercise I am able to adjust my eating plan
Cannot do at all Certain can do
1 2 3 4 5 6
11.1 am able to follow a healthy eating pattern when I am away from home
Cannot do at all Certain can do
1 2 3 4 5 6
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12.1 am able to follow a healthy eating pattern when I am out at a party
Cannot do at all Certain can do
1 2 3 4 5 6
13.1 am able to adjust my eating plan when 1am feeling stressed or anxious
Cannot do at all Certain can do
1 2 3 4 5 6
14.1 am able to take my medication as prescribed
Cannot do at all Certain can do
1 2 3 4 5 6
15. I am able to adjust my medication when I am ill
Cannot do at all Certain can do
1 2 3 4 5 6
The next question is about your information needs:
16. Following your hospital discharge, to what extent have your information needs been 
met?
1 2 3 4 5 6
Unmet Totally met
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The last question is about the information you would like to receive 
about your medication.
17. What information is important to you in an explanation about your medicine?
Please rate each of the following types of information (from 1 not all important to 6 
very important) for how important you feel it is to be included in an explanation about 
the medicine. (Please place a 13 in the box o f your choice)
Not at all Very important 
important
1 2 4 . 5 6
What the medication is (drug type etc)
What the medication does / how it works
Probability medicine will work
Detailed questions about taking medicine 
(e.g. dosage)
Possible side effects
Interactions with other medicines
Any alternatives to medication
What to do if you forget to take it or take 
too much
How will you know if medication is 
working
Risks of not taking medication
How to contact the nurse/doctor
Other
188
Thank you for taking the time to complete the questionnaire 
Please check that you have filled in each question and return it in the
envelope provided 
This information is covered by the Data Protection Act
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The University of Reading
The University of Reading 
School of Health and Social Care 
Bulmershe Court 
Reading 
RG6 1HY
Tel: 0118 3785840
Date as posted
Dear
Self-efficacy (or confidence") questionnaire for people living with diabetes
During your recent stay in hospital you completed part 1 and 2 of the above study. You were 
asked to participate in this research because you have diabetes and you have your medicines 
prescribed by a nurse and/or doctor. I am interested in your views about managing your 
diabetes and the medication you have been prescribed. The information we gain from you will 
be used to help inform the future development do prescribing in nursing.
The study compromises of three similar questionnaires. This is the final part of the study. The 
questionnaire will take about 10 minutes to complete. A stamped addressed envelope (SAE) is 
enclosed for you to return it to me. If you feel, after reading this information, that you do not 
want to take part in this study, please return the questionnaire in the envelope provided. The 
research will be complete by June 2006, and the results will be made available to you via the 
Diabetic Specialist Nurse when you next attend the hospital out-patient clinic. Your 
participation in this survey is entirely voluntary, and your responses will be confidential and 
anonymous.
If you have any questions, or require help completing the questionnaire, please do not hesitate 
to contact me. Thank you for reading this letter and I look forward to receiving your 
completed questionnaire.
Thank you for your participation
Yours Sincerely
Nicola Carey 
Senior Research Fellow
Q3 letter 190
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The University of Reading
The University of Reading 
School of Health and Social Care 
Bulmershe Court 
Reading 
RG6 1HY
Tel: 0118 3785840
Date as posted
Dear
Self-efficacy Cor confidence") questionnaire for people living with diabetes
During your recent stay in hospital you completed part 1 and 2 of the above study. You were 
asked to participate in this research because you have diabetes and you have your medicines 
prescribed by a nurse and/or doctor. I am interested in your views about managing your 
diabetes and the medication you have been prescribed. The information we gain from you will 
be used to help inform the future development do prescribing in nursing.
The study compromises of three similar questionnaires. This is the final part of the study. The 
questionnaire will take about 10 minutes to complete. A stamped addressed envelope (SAE) is 
enclosed for you to return it to me. If you feel, after reading this information, that you do not 
want to take part in this study, please return the questionnaire in the envelope provided. The 
research will be complete by June 2006, and the results will be made available to you via the 
Diabetic Specialist Nurse when you next attend the hospital out patient clinic. Your 
participation in this survey is entirely voluntary, and your responses will be confidential and 
anonymous.
If you have any questions, or require help completing the questionnaire, please do not hesitate 
to contact me. Thank you for reading this letter and I look forward to receiving your 
completed questionnaire.
If you have already completed the questionnaire please ignore this letter.
Thank you for your participation 
Yours Sincerely
Nicola Carey 
Senior Research Fellow
Q3 reminder 191
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The University of Reading
School of Health and Social Care 
University of Reading 
Bulmershe Court 
Reading 
RG6 1HY
Date as posted
Dear
Self-efficacy tor confidence) questionnaire for people living with diabetes
I am writing to thank you for your participation in this study. I am very grateful for your co­
operation and I hope that the questionnaires will provide important insight in to the effect of the 
Diabetic Specialist Nurse Prescriber on self-efficacy (confidence) for people living with diabetes. 
The investigation will be complete by June 2006, and the results will be made available to you via 
the Diabetic Specialist Nurse when you next attend the hospital out patient clinic.
Thank you for your participation
Yours Sincerely
Nicola Carey 
Senior Research Fellow
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